Correlation between copy number variation genes (focal events) and selected clinical features
Uterine Corpus Endometrioid Carcinoma (Primary solid tumor)
02 April 2015  |  analyses__2015_04_02
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2015): Correlation between copy number variation genes (focal events) and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C13X85SQ
Overview
Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 100 focal events and 7 clinical features across 528 patients, 443 significant findings detected with Q value < 0.25.

  • amp_1p35.2 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_1p34.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_1p22.3 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'ETHNICITY'.

  • amp_1q21.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_1q22 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_1q44 cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.

  • amp_2p24.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • amp_2q13 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • amp_3p25.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_3p14.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'RACE', and 'ETHNICITY'.

  • amp_3q26.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_3q26.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_4p16.3 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.

  • amp_5p15.33 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_5q35.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_6p24.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • amp_6p22.3 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_6q25.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_7q31.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • amp_8p11.22 cnv correlated to 'Time to Death'.

  • amp_8p11.21 cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.

  • amp_8q24.21 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • amp_8q24.21 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.

  • amp_9p24.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.

  • amp_9q34.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_10q22.2 cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • amp_11p11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • amp_11q13.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • amp_11q14.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_12p12.1 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RACE', and 'ETHNICITY'.

  • amp_12q13.11 cnv correlated to 'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_12q13.2 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_13q34 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_14q24.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • amp_14q32.33 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_15q26.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.

  • amp_16p11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_17q11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_17q12 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_17q25.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_18p11.31 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_18q11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_19p13.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_19q12 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_20p13 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • amp_20q11.21 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_20q13.12 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_20q13.33 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_22q12.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • amp_xp11.23 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • amp_xq28 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • del_1p36.21 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.

  • del_1p36.11 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.

  • del_2p25.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • del_2q22.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_2q37.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_3p14.2 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RACE', and 'ETHNICITY'.

  • del_3q13.31 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.

  • del_4p16.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • del_4p15.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • del_4q22.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.

  • del_4q34.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_5q12.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_6q26 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.

  • del_7p22.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_7q11.22 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.

  • del_7q31.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_7q36.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • del_8p23.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_8p21.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_9p23 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_9q21.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_9q34.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • del_10q23.31 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • del_11p15.5 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_11q14.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'RACE', and 'ETHNICITY'.

  • del_11q25 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_12q23.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_12q24.33 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.

  • del_13q11 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.

  • del_13q14.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_14q13.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_15q15.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_15q23 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_16p13.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_16q21 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_16q22.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_16q23.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_17p13.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_17p11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_17q11.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.

  • del_17q21.31 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.

  • del_18q21.2 cnv correlated to 'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_18q23 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION',  'RACE', and 'ETHNICITY'.

  • del_19p13.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

  • del_19p12 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_19q13.43 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.

  • del_20p12.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.

  • del_22q13.32 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.

  • del_xp21.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'HISTOLOGICAL_TYPE',  'COMPLETENESS_OF_RESECTION', and 'RACE'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 100 focal events and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 443 significant findings detected.

Clinical
Features
Time
to
Death
YEARS
TO
BIRTH
HISTOLOGICAL
TYPE
RADIATIONS
RADIATION
REGIMENINDICATION
COMPLETENESS
OF
RESECTION
RACE ETHNICITY
nCNV (%) nWild-Type logrank test Wilcoxon-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test
del 18q23 95 (18%) 433 0.0051
(0.0141)
0.000443
(0.00168)
1e-05
(5.88e-05)
0.000482
(0.00181)
0.0122
(0.0291)
0.0608
(0.114)
0.149
(0.236)
amp 3p14 1 63 (12%) 465 0.00125
(0.00421)
0.00377
(0.011)
8e-05
(0.000397)
0.0476
(0.0932)
0.263
(0.368)
0.0109
(0.0264)
0.0802
(0.145)
amp 5p15 33 88 (17%) 440 0.000241
(0.001)
0.000107
(0.000504)
1e-05
(5.88e-05)
0.113
(0.191)
0.133
(0.22)
0.00247
(0.00758)
0.277
(0.384)
amp 18p11 31 94 (18%) 434 0.00693
(0.0177)
8.63e-05
(0.000422)
1e-05
(5.88e-05)
0.0204
(0.0451)
0.0266
(0.0567)
0.00112
(0.00385)
1
(1.00)
amp 20q11 21 149 (28%) 379 0.000289
(0.00116)
1.88e-08
(1.2e-06)
1e-05
(5.88e-05)
0.00612
(0.0161)
0.106
(0.182)
0.00654
(0.017)
0.542
(0.637)
amp 20q13 12 149 (28%) 379 0.00947
(0.0234)
1.34e-08
(1e-06)
1e-05
(5.88e-05)
0.00104
(0.00369)
0.0596
(0.112)
0.00522
(0.0143)
0.554
(0.648)
amp 20q13 33 150 (28%) 378 0.014
(0.0326)
3.51e-08
(1.75e-06)
1e-05
(5.88e-05)
0.00101
(0.00362)
0.0133
(0.0313)
0.0395
(0.0806)
1
(1.00)
amp 22q12 2 62 (12%) 466 0.000495
(0.00185)
0.000572
(0.00212)
1e-05
(5.88e-05)
0.0474
(0.0932)
0.00228
(0.00709)
0.0256
(0.0548)
0.675
(0.762)
del 2q22 1 46 (9%) 482 1.26e-07
(5.19e-06)
0.0048
(0.0134)
1e-05
(5.88e-05)
0.0027
(0.00814)
0.00162
(0.00525)
0.0849
(0.152)
1
(1.00)
del 2q37 3 52 (10%) 476 0.0185
(0.0413)
0.00257
(0.00787)
0.0001
(0.000473)
0.137
(0.223)
0.0439
(0.0871)
0.142
(0.228)
1
(1.00)
del 4q34 3 127 (24%) 401 0.00667
(0.0172)
6.72e-07
(2.35e-05)
1e-05
(5.88e-05)
0.134
(0.221)
0.137
(0.224)
0.0115
(0.0277)
1
(1.00)
del 8p23 2 115 (22%) 413 0.000772
(0.00282)
2.17e-05
(0.00012)
1e-05
(5.88e-05)
0.122
(0.205)
0.0585
(0.111)
0.00564
(0.0151)
0.319
(0.422)
del 8p21 2 113 (21%) 415 0.00679
(0.0174)
2.6e-06
(5.88e-05)
1e-05
(5.88e-05)
0.151
(0.24)
0.146
(0.233)
0.00731
(0.0186)
0.743
(0.808)
del 11p15 5 102 (19%) 426 0.0163
(0.037)
1.22e-05
(6.98e-05)
1e-05
(5.88e-05)
0.00584
(0.0155)
0.0897
(0.159)
0.0548
(0.105)
0.498
(0.593)
del 11q14 1 70 (13%) 458 0.0903
(0.16)
0.000288
(0.00116)
1e-05
(5.88e-05)
0.0591
(0.112)
0.65
(0.738)
0.0717
(0.132)
0.0431
(0.0857)
del 12q23 1 53 (10%) 475 0.000179
(0.000803)
0.00236
(0.00727)
1e-05
(5.88e-05)
0.0491
(0.0956)
0.041
(0.083)
0.0413
(0.0831)
1
(1.00)
del 15q15 1 136 (26%) 392 7.04e-05
(0.000357)
2.37e-08
(1.38e-06)
1e-05
(5.88e-05)
0.0131
(0.0308)
0.0396
(0.0806)
0.0549
(0.105)
1
(1.00)
del 16p13 3 90 (17%) 438 0.00536
(0.0145)
2.2e-06
(5.88e-05)
1e-05
(5.88e-05)
0.0682
(0.127)
0.105
(0.181)
0.0297
(0.0618)
1
(1.00)
del 17p13 3 119 (23%) 409 0.000112
(0.000522)
0.000232
(0.000974)
1e-05
(5.88e-05)
0.0451
(0.0889)
0.146
(0.233)
0.00155
(0.00507)
1
(1.00)
del 17q21 31 109 (21%) 419 0.000198
(0.000864)
1.18e-05
(6.85e-05)
1e-05
(5.88e-05)
0.0522
(0.101)
0.0707
(0.131)
0.174
(0.267)
0.0481
(0.094)
del 19p13 3 151 (29%) 377 7.09e-06
(5.88e-05)
1.35e-10
(4.73e-08)
1e-05
(5.88e-05)
0.0815
(0.147)
0.00614
(0.0161)
0.00027
(0.00111)
0.241
(0.343)
amp 1p34 2 72 (14%) 456 0.00499
(0.0138)
9.18e-05
(0.00044)
1e-05
(5.88e-05)
0.254
(0.358)
0.0924
(0.163)
0.0283
(0.0597)
0.698
(0.781)
amp 3p25 1 80 (15%) 448 0.031
(0.0639)
0.000276
(0.00113)
1e-05
(5.88e-05)
0.0992
(0.173)
0.695
(0.78)
0.00328
(0.00969)
0.47
(0.572)
amp 3q26 2 171 (32%) 357 0.000911
(0.00327)
2.54e-11
(1.78e-08)
1e-05
(5.88e-05)
0.0273
(0.0577)
0.306
(0.412)
2e-05
(0.000111)
0.563
(0.655)
amp 3q26 2 159 (30%) 369 0.00286
(0.00857)
3.3e-09
(4.62e-07)
1e-05
(5.88e-05)
0.0533
(0.103)
0.201
(0.298)
0.00015
(0.000686)
0.243
(0.345)
amp 8q24 21 212 (40%) 316 0.000397
(0.00152)
0.0149
(0.0343)
1e-05
(5.88e-05)
0.00359
(0.0105)
0.0114
(0.0276)
0.566
(0.658)
0.786
(0.84)
amp 9p24 2 64 (12%) 464 0.0302
(0.0625)
0.00194
(0.00614)
1e-05
(5.88e-05)
0.291
(0.396)
0.135
(0.222)
0.166
(0.26)
0.0214
(0.0472)
amp 11q14 1 56 (11%) 472 5.34e-07
(1.97e-05)
0.0108
(0.0263)
1e-05
(5.88e-05)
0.15
(0.237)
0.335
(0.44)
0.101
(0.176)
1
(1.00)
amp 12q13 2 97 (18%) 431 0.697
(0.78)
0.113
(0.192)
1e-05
(5.88e-05)
0.0561
(0.106)
0.124
(0.207)
0.124
(0.207)
0.745
(0.809)
amp 14q32 33 76 (14%) 452 0.00433
(0.0123)
0.00112
(0.00385)
1e-05
(5.88e-05)
0.00784
(0.0197)
0.401
(0.508)
0.0198
(0.0439)
0.703
(0.783)
amp 15q26 3 37 (7%) 491 0.00146
(0.00479)
0.00329
(0.00969)
9e-05
(0.000434)
0.081
(0.146)
0.0122
(0.0291)
0.787
(0.84)
0.346
(0.453)
amp 16p11 2 64 (12%) 464 0.0156
(0.0359)
0.000343
(0.00134)
1e-05
(5.88e-05)
0.451
(0.553)
0.0732
(0.135)
0.0954
(0.167)
0.692
(0.778)
amp 17q11 2 71 (13%) 457 0.00184
(0.00588)
0.00579
(0.0154)
1e-05
(5.88e-05)
0.313
(0.418)
0.00113
(0.00386)
0.00234
(0.00725)
0.404
(0.509)
amp 18q11 2 68 (13%) 460 0.00841
(0.021)
0.00197
(0.00623)
1e-05
(5.88e-05)
0.383
(0.49)
0.0755
(0.138)
0.00519
(0.0142)
1
(1.00)
amp 19p13 2 97 (18%) 431 0.0128
(0.0303)
4.56e-10
(9.41e-08)
1e-05
(5.88e-05)
0.0561
(0.106)
0.301
(0.408)
0.00133
(0.00443)
1
(1.00)
del 4q22 1 102 (19%) 426 0.00539
(0.0145)
8e-06
(5.88e-05)
1e-05
(5.88e-05)
0.135
(0.222)
0.0787
(0.144)
0.238
(0.34)
0.737
(0.806)
del 9p23 76 (14%) 452 0.0163
(0.037)
0.00143
(0.00473)
1e-05
(5.88e-05)
0.0491
(0.0956)
0.331
(0.436)
0.13
(0.215)
0.703
(0.783)
del 9q21 2 126 (24%) 402 1.41e-05
(8.05e-05)
5.38e-10
(9.41e-08)
1e-05
(5.88e-05)
0.135
(0.221)
0.173
(0.267)
0.0288
(0.0605)
0.751
(0.812)
del 11q25 92 (17%) 436 0.00906
(0.0224)
0.000253
(0.00105)
1e-05
(5.88e-05)
0.00266
(0.0081)
0.39
(0.497)
0.0842
(0.151)
0.725
(0.799)
del 12q24 33 63 (12%) 465 0.00562
(0.0151)
2.22e-05
(0.000121)
1e-05
(5.88e-05)
0.0219
(0.0481)
0.0267
(0.0567)
0.29
(0.396)
1
(1.00)
del 13q14 2 103 (20%) 425 0.00126
(0.00423)
0.00137
(0.00454)
1e-05
(5.88e-05)
0.009
(0.0223)
0.403
(0.509)
0.154
(0.243)
0.192
(0.291)
del 15q23 113 (21%) 415 0.0119
(0.0286)
8.57e-06
(5.88e-05)
1e-05
(5.88e-05)
0.0551
(0.105)
0.431
(0.534)
0.0338
(0.0691)
0.318
(0.422)
del 16q21 150 (28%) 378 0.00957
(0.0235)
1.31e-08
(1e-06)
1e-05
(5.88e-05)
0.082
(0.148)
0.23
(0.331)
0.0232
(0.0507)
0.765
(0.825)
del 16q23 1 162 (31%) 366 0.00282
(0.00847)
8.79e-09
(8.79e-07)
1e-05
(5.88e-05)
0.201
(0.298)
0.0173
(0.039)
0.00318
(0.00943)
1
(1.00)
del 17p11 2 124 (23%) 404 0.000381
(0.00148)
4.49e-06
(5.88e-05)
1e-05
(5.88e-05)
0.105
(0.182)
0.514
(0.611)
0.0125
(0.0296)
1
(1.00)
del 18q21 2 89 (17%) 439 0.427
(0.532)
0.0003
(0.0012)
1e-05
(5.88e-05)
0.00383
(0.0111)
0.129
(0.214)
0.0696
(0.13)
0.288
(0.395)
del 19p12 57 (11%) 471 0.0869
(0.155)
0.0143
(0.0332)
1e-05
(5.88e-05)
0.0256
(0.0548)
0.166
(0.26)
0.126
(0.21)
0.659
(0.746)
del 22q13 32 136 (26%) 392 0.000218
(0.000919)
1.05e-07
(4.59e-06)
1e-05
(5.88e-05)
0.0242
(0.0525)
0.288
(0.395)
0.0157
(0.0359)
0.224
(0.324)
del xp21 1 84 (16%) 444 1.97e-05
(0.000111)
0.000139
(0.00064)
1e-05
(5.88e-05)
0.178
(0.272)
0.125
(0.208)
0.00411
(0.0117)
0.254
(0.358)
amp 1q21 3 236 (45%) 292 0.0153
(0.0353)
5.3e-06
(5.88e-05)
2e-05
(0.000111)
0.237
(0.34)
0.647
(0.738)
0.00663
(0.0171)
0.276
(0.383)
amp 1q22 249 (47%) 279 0.000798
(0.00289)
4.65e-08
(2.17e-06)
1e-05
(5.88e-05)
0.431
(0.534)
0.284
(0.392)
0.0165
(0.0374)
0.42
(0.525)
amp 2p24 3 118 (22%) 410 6.26e-05
(0.000324)
0.0135
(0.0316)
1e-05
(5.88e-05)
0.0251
(0.0542)
0.723
(0.799)
0.433
(0.537)
0.203
(0.3)
amp 5q35 3 53 (10%) 475 0.00614
(0.0161)
0.000282
(0.00115)
1e-05
(5.88e-05)
0.194
(0.292)
0.522
(0.619)
0.0197
(0.0438)
0.388
(0.495)
amp 6p24 2 114 (22%) 414 0.0559
(0.106)
2.5e-06
(5.88e-05)
1e-05
(5.88e-05)
0.0937
(0.164)
0.733
(0.804)
0.162
(0.255)
0.744
(0.808)
amp 6p22 3 104 (20%) 424 0.352
(0.459)
0.000195
(0.000856)
1e-05
(5.88e-05)
0.108
(0.185)
0.553
(0.648)
0.00738
(0.0187)
0.484
(0.582)
amp 6q25 1 84 (16%) 444 0.0921
(0.163)
0.00172
(0.00555)
1e-05
(5.88e-05)
0.42
(0.525)
0.17
(0.264)
0.00526
(0.0143)
0.704
(0.783)
amp 7q31 2 90 (17%) 438 8.52e-07
(2.73e-05)
0.0795
(0.144)
7e-05
(0.000357)
0.0184
(0.0413)
0.45
(0.553)
0.764
(0.825)
0.482
(0.581)
amp 8p11 21 161 (30%) 367 1.13e-05
(6.56e-05)
0.918
(0.966)
1e-05
(5.88e-05)
0.019
(0.0423)
0.00642
(0.0168)
0.184
(0.28)
0.562
(0.655)
amp 8q24 21 206 (39%) 322 0.000217
(0.000919)
0.0412
(0.083)
1e-05
(5.88e-05)
0.00478
(0.0134)
0.199
(0.296)
0.159
(0.25)
0.418
(0.523)
amp 9q34 3 38 (7%) 490 0.0429
(0.0855)
0.00159
(0.00516)
1e-05
(5.88e-05)
0.708
(0.785)
0.557
(0.651)
0.00983
(0.0241)
0.612
(0.705)
amp 12p12 1 92 (17%) 436 0.95
(0.996)
0.145
(0.232)
1e-05
(5.88e-05)
0.299
(0.406)
0.634
(0.726)
0.117
(0.198)
0.145
(0.232)
amp 13q34 57 (11%) 471 0.526
(0.622)
8.49e-05
(0.000418)
1e-05
(5.88e-05)
0.874
(0.927)
0.0141
(0.0327)
0.0622
(0.116)
1
(1.00)
amp 17q12 74 (14%) 454 0.000384
(0.00148)
0.0027
(0.00814)
1e-05
(5.88e-05)
1
(1.00)
0.261
(0.367)
0.0053
(0.0144)
1
(1.00)
amp 17q25 1 102 (19%) 426 0.000212
(0.000903)
0.00112
(0.00385)
1e-05
(5.88e-05)
0.457
(0.558)
0.175
(0.268)
8e-05
(0.000397)
0.318
(0.422)
amp 19q12 116 (22%) 412 4.99e-05
(0.000265)
1.44e-08
(1e-06)
1e-05
(5.88e-05)
0.285
(0.393)
0.217
(0.316)
3e-05
(0.000162)
1
(1.00)
amp 20p13 116 (22%) 412 0.307
(0.412)
2.37e-06
(5.88e-05)
1e-05
(5.88e-05)
0.033
(0.0678)
0.518
(0.615)
0.0445
(0.088)
0.317
(0.422)
amp xp11 23 89 (17%) 439 0.0887
(0.158)
0.029
(0.0605)
0.00034
(0.00134)
0.025
(0.0541)
0.486
(0.584)
0.942
(0.988)
0.48
(0.58)
del 1p36 11 79 (15%) 449 0.00773
(0.0195)
9.85e-05
(0.000469)
1e-05
(5.88e-05)
0.49
(0.587)
0.0421
(0.0845)
0.344
(0.451)
0.247
(0.349)
del 2p25 3 26 (5%) 502 0.0429
(0.0855)
0.071
(0.132)
0.0104
(0.0254)
0.109
(0.185)
0.291
(0.396)
0.449
(0.553)
1
(1.00)
del 3p14 2 77 (15%) 451 0.264
(0.369)
0.00112
(0.00385)
1e-05
(5.88e-05)
0.264
(0.369)
0.774
(0.833)
0.022
(0.0482)
0.141
(0.228)
del 4p15 2 93 (18%) 435 0.00057
(0.00212)
7.19e-05
(0.000362)
1e-05
(5.88e-05)
0.0929
(0.163)
0.491
(0.587)
0.349
(0.455)
0.306
(0.412)
del 5q12 1 109 (21%) 419 0.00485
(0.0135)
6.11e-06
(5.88e-05)
1e-05
(5.88e-05)
0.227
(0.327)
0.705
(0.783)
0.0747
(0.137)
0.192
(0.291)
del 7p22 3 70 (13%) 458 0.00112
(0.00385)
6.52e-05
(0.000336)
1e-05
(5.88e-05)
0.472
(0.572)
0.274
(0.381)
0.119
(0.201)
0.692
(0.778)
del 7q31 1 53 (10%) 475 0.0267
(0.0567)
5.65e-05
(0.000295)
1e-05
(5.88e-05)
1
(1.00)
0.413
(0.518)
0.114
(0.192)
1
(1.00)
del 9q34 2 128 (24%) 400 0.000133
(0.000615)
2.65e-08
(1.42e-06)
1e-05
(5.88e-05)
0.109
(0.185)
0.21
(0.309)
0.159
(0.25)
1
(1.00)
del 10q23 31 75 (14%) 453 0.00423
(0.012)
0.000879
(0.00317)
1e-05
(5.88e-05)
0.00452
(0.0128)
0.221
(0.321)
0.319
(0.422)
1
(1.00)
del 13q11 94 (18%) 434 0.00311
(0.00928)
0.00111
(0.00385)
1e-05
(5.88e-05)
0.0397
(0.0806)
0.193
(0.291)
0.319
(0.422)
0.306
(0.412)
del 14q13 1 71 (13%) 457 0.00804
(0.0202)
0.00402
(0.0115)
1e-05
(5.88e-05)
0.471
(0.572)
1
(1.00)
0.00394
(0.0113)
0.409
(0.513)
del 16q22 3 154 (29%) 374 0.0289
(0.0605)
5.81e-09
(6.78e-07)
1e-05
(5.88e-05)
0.196
(0.293)
0.2
(0.298)
0.0323
(0.0665)
1
(1.00)
del 19q13 43 65 (12%) 463 0.00191
(0.00608)
0.000307
(0.00122)
1e-05
(5.88e-05)
0.37
(0.476)
0.0255
(0.0548)
0.191
(0.29)
0.232
(0.333)
del 20p12 1 35 (7%) 493 8.85e-05
(0.00043)
0.14
(0.228)
0.0002
(0.000864)
1
(1.00)
0.106
(0.182)
0.178
(0.272)
0.289
(0.396)
amp 1p35 2 55 (10%) 473 0.209
(0.307)
0.000173
(0.000783)
1e-05
(5.88e-05)
0.747
(0.81)
0.257
(0.361)
0.144
(0.231)
0.635
(0.727)
amp 1p22 3 95 (18%) 433 0.457
(0.558)
0.00124
(0.00421)
0.00018
(0.000803)
0.443
(0.548)
0.898
(0.947)
0.343
(0.451)
0.14
(0.227)
amp 2q13 116 (22%) 412 4.22e-05
(0.000225)
0.00032
(0.00126)
1e-05
(5.88e-05)
0.406
(0.511)
0.246
(0.349)
0.211
(0.309)
0.743
(0.808)
amp 11p11 2 50 (9%) 478 0.00175
(0.00563)
0.000211
(0.000903)
1e-05
(5.88e-05)
0.738
(0.806)
0.648
(0.738)
0.358
(0.465)
0.36
(0.465)
amp 11q13 2 70 (13%) 458 0.00465
(0.0131)
0.000622
(0.00228)
1e-05
(5.88e-05)
0.472
(0.572)
0.176
(0.269)
0.665
(0.752)
1
(1.00)
amp 12q13 11 84 (16%) 444 0.592
(0.685)
0.651
(0.738)
1e-05
(5.88e-05)
0.106
(0.182)
0.308
(0.413)
0.0178
(0.04)
0.482
(0.581)
amp 14q24 3 63 (12%) 465 0.000162
(0.000736)
0.00117
(0.00398)
1e-05
(5.88e-05)
0.172
(0.267)
0.388
(0.495)
0.399
(0.507)
0.681
(0.767)
amp xq28 89 (17%) 439 0.000466
(0.00176)
0.0513
(0.0994)
0.00059
(0.00217)
0.896
(0.946)
0.207
(0.304)
0.527
(0.622)
0.713
(0.789)
del 4p16 3 89 (17%) 439 0.00202
(0.00633)
0.000181
(0.000803)
1e-05
(5.88e-05)
0.359
(0.465)
0.855
(0.908)
0.31
(0.415)
0.728
(0.8)
del 7q36 1 62 (12%) 466 0.00848
(0.0211)
3.24e-07
(1.26e-05)
1e-05
(5.88e-05)
0.649
(0.738)
0.369
(0.476)
0.389
(0.495)
1
(1.00)
del 17q11 2 101 (19%) 427 0.0291
(0.0605)
8.58e-07
(2.73e-05)
1e-05
(5.88e-05)
0.169
(0.263)
0.23
(0.331)
0.777
(0.833)
0.737
(0.806)
amp 1q44 213 (40%) 315 0.0718
(0.132)
0.00104
(0.00369)
0.45
(0.553)
0.616
(0.707)
0.496
(0.592)
0.195
(0.293)
0.169
(0.263)
amp 4p16 3 52 (10%) 476 0.24
(0.342)
2.74e-05
(0.000149)
1e-05
(5.88e-05)
0.51
(0.607)
0.197
(0.294)
0.543
(0.638)
0.36
(0.465)
amp 10q22 2 143 (27%) 385 0.0931
(0.163)
0.213
(0.312)
0.00337
(0.00987)
0.378
(0.485)
0.447
(0.552)
0.575
(0.667)
0.766
(0.825)
del 1p36 21 69 (13%) 459 0.22
(0.32)
0.000199
(0.000864)
1e-05
(5.88e-05)
0.884
(0.937)
0.567
(0.658)
0.204
(0.302)
0.399
(0.507)
del 3q13 31 42 (8%) 486 0.776
(0.833)
0.000389
(0.0015)
1e-05
(5.88e-05)
0.28
(0.387)
0.823
(0.877)
0.784
(0.839)
1
(1.00)
del 6q26 45 (9%) 483 0.174
(0.267)
0.00651
(0.0169)
1e-05
(5.88e-05)
0.598
(0.69)
0.931
(0.978)
0.887
(0.938)
0.614
(0.706)
del 7q11 22 39 (7%) 489 0.987
(1.00)
5.17e-05
(0.000272)
1e-05
(5.88e-05)
0.708
(0.785)
0.607
(0.7)
0.464
(0.566)
1
(1.00)
amp 8p11 22 125 (24%) 403 0.00209
(0.00652)
0.217
(0.316)
0.828
(0.881)
0.355
(0.462)
0.727
(0.8)
0.292
(0.397)
0.532
(0.627)
'amp_1p35.2' versus 'YEARS_TO_BIRTH'

P value = 0.000173 (Wilcoxon-test), Q value = 0.00078

Table S1.  Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 1(1P35.2) MUTATED 54 68.7 (8.8)
AMP PEAK 1(1P35.2) WILD-TYPE 472 63.5 (11.3)

Figure S1.  Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p35.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S2.  Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 1(1P35.2) MUTATED 16 5 34
AMP PEAK 1(1P35.2) WILD-TYPE 379 16 78

Figure S2.  Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p35.2' versus 'RACE'

P value = 0.144 (Fisher's exact test), Q value = 0.23

Table S3.  Gene #1: 'amp_1p35.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 1(1P35.2) MUTATED 0 1 15 2 30
AMP PEAK 1(1P35.2) WILD-TYPE 4 19 86 7 336

Figure S3.  Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #6: 'RACE'

'amp_1p34.2' versus 'Time to Death'

P value = 0.00499 (logrank test), Q value = 0.014

Table S4.  Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 2(1P34.2) MUTATED 72 17 0.1 - 125.4 (22.1)
AMP PEAK 2(1P34.2) WILD-TYPE 454 52 0.1 - 191.8 (23.4)

Figure S4.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

'amp_1p34.2' versus 'YEARS_TO_BIRTH'

P value = 9.18e-05 (Wilcoxon-test), Q value = 0.00044

Table S5.  Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 2(1P34.2) MUTATED 71 68.6 (9.4)
AMP PEAK 2(1P34.2) WILD-TYPE 455 63.3 (11.3)

Figure S5.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S6.  Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 2(1P34.2) MUTATED 21 7 44
AMP PEAK 2(1P34.2) WILD-TYPE 374 14 68

Figure S6.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p34.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0924 (Fisher's exact test), Q value = 0.16

Table S7.  Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 2(1P34.2) MUTATED 44 4 5 7
AMP PEAK 2(1P34.2) WILD-TYPE 319 19 12 28

Figure S7.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_1p34.2' versus 'RACE'

P value = 0.0283 (Fisher's exact test), Q value = 0.06

Table S8.  Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 2(1P34.2) MUTATED 0 1 22 2 39
AMP PEAK 2(1P34.2) WILD-TYPE 4 19 79 7 327

Figure S8.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

'amp_1p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.00124 (Wilcoxon-test), Q value = 0.0042

Table S9.  Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 3(1P22.3) MUTATED 95 67.2 (9.6)
AMP PEAK 3(1P22.3) WILD-TYPE 431 63.3 (11.4)

Figure S9.  Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.00018 (Fisher's exact test), Q value = 8e-04

Table S10.  Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 3(1P22.3) MUTATED 55 5 35
AMP PEAK 3(1P22.3) WILD-TYPE 340 16 77

Figure S10.  Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p22.3' versus 'ETHNICITY'

P value = 0.14 (Fisher's exact test), Q value = 0.23

Table S11.  Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
AMP PEAK 3(1P22.3) MUTATED 0 64
AMP PEAK 3(1P22.3) WILD-TYPE 14 303

Figure S11.  Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

'amp_1q21.3' versus 'Time to Death'

P value = 0.0153 (logrank test), Q value = 0.035

Table S12.  Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 4(1Q21.3) MUTATED 235 39 0.1 - 149.6 (20.8)
AMP PEAK 4(1Q21.3) WILD-TYPE 291 30 0.2 - 191.8 (24.3)

Figure S12.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

'amp_1q21.3' versus 'YEARS_TO_BIRTH'

P value = 5.3e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S13.  Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 4(1Q21.3) MUTATED 236 66.6 (10.3)
AMP PEAK 4(1Q21.3) WILD-TYPE 290 61.9 (11.5)

Figure S13.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q21.3' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S14.  Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 4(1Q21.3) MUTATED 154 10 72
AMP PEAK 4(1Q21.3) WILD-TYPE 241 11 40

Figure S14.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1q21.3' versus 'RACE'

P value = 0.00663 (Fisher's exact test), Q value = 0.017

Table S15.  Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 4(1Q21.3) MUTATED 2 5 59 2 156
AMP PEAK 4(1Q21.3) WILD-TYPE 2 15 42 7 210

Figure S15.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

'amp_1q22' versus 'Time to Death'

P value = 0.000798 (logrank test), Q value = 0.0029

Table S16.  Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 5(1Q22) MUTATED 249 44 0.1 - 149.6 (20.9)
AMP PEAK 5(1Q22) WILD-TYPE 277 25 0.2 - 191.8 (24.3)

Figure S16.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

'amp_1q22' versus 'YEARS_TO_BIRTH'

P value = 4.65e-08 (Wilcoxon-test), Q value = 2.2e-06

Table S17.  Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 5(1Q22) MUTATED 249 66.9 (10.4)
AMP PEAK 5(1Q22) WILD-TYPE 277 61.4 (11.3)

Figure S17.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S18.  Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 5(1Q22) MUTATED 160 10 79
AMP PEAK 5(1Q22) WILD-TYPE 235 11 33

Figure S18.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1q22' versus 'RACE'

P value = 0.0165 (Fisher's exact test), Q value = 0.037

Table S19.  Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 5(1Q22) MUTATED 2 5 59 2 170
AMP PEAK 5(1Q22) WILD-TYPE 2 15 42 7 196

Figure S19.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

'amp_1q44' versus 'Time to Death'

P value = 0.0718 (logrank test), Q value = 0.13

Table S20.  Gene #6: 'amp_1q44' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 6(1Q44) MUTATED 212 34 0.1 - 149.6 (21.1)
AMP PEAK 6(1Q44) WILD-TYPE 314 35 0.2 - 191.8 (23.9)

Figure S20.  Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #1: 'Time to Death'

'amp_1q44' versus 'YEARS_TO_BIRTH'

P value = 0.00104 (Wilcoxon-test), Q value = 0.0037

Table S21.  Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 6(1Q44) MUTATED 213 66.0 (10.4)
AMP PEAK 6(1Q44) WILD-TYPE 313 62.6 (11.6)

Figure S21.  Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2p24.3' versus 'Time to Death'

P value = 6.26e-05 (logrank test), Q value = 0.00032

Table S22.  Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 7(2P24.3) MUTATED 117 28 0.1 - 149.6 (22.3)
AMP PEAK 7(2P24.3) WILD-TYPE 409 41 0.1 - 191.8 (23.4)

Figure S22.  Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

'amp_2p24.3' versus 'YEARS_TO_BIRTH'

P value = 0.0135 (Wilcoxon-test), Q value = 0.032

Table S23.  Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 7(2P24.3) MUTATED 117 66.2 (10.4)
AMP PEAK 7(2P24.3) WILD-TYPE 409 63.4 (11.4)

Figure S23.  Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2p24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S24.  Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 7(2P24.3) MUTATED 54 7 57
AMP PEAK 7(2P24.3) WILD-TYPE 341 14 55

Figure S24.  Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_2p24.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0251 (Fisher's exact test), Q value = 0.054

Table S25.  Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 7(2P24.3) MUTATED 22 96
AMP PEAK 7(2P24.3) WILD-TYPE 119 291

Figure S25.  Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_2q13' versus 'Time to Death'

P value = 4.22e-05 (logrank test), Q value = 0.00023

Table S26.  Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 8(2Q13) MUTATED 115 28 0.3 - 149.6 (20.9)
AMP PEAK 8(2Q13) WILD-TYPE 411 41 0.1 - 191.8 (23.9)

Figure S26.  Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

'amp_2q13' versus 'YEARS_TO_BIRTH'

P value = 0.00032 (Wilcoxon-test), Q value = 0.0013

Table S27.  Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 8(2Q13) MUTATED 115 67.1 (9.1)
AMP PEAK 8(2Q13) WILD-TYPE 411 63.2 (11.6)

Figure S27.  Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2q13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S28.  Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 8(2Q13) MUTATED 44 5 67
AMP PEAK 8(2Q13) WILD-TYPE 351 16 45

Figure S28.  Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'Time to Death'

P value = 0.031 (logrank test), Q value = 0.064

Table S29.  Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 9(3P25.1) MUTATED 80 18 0.1 - 191.8 (27.1)
AMP PEAK 9(3P25.1) WILD-TYPE 446 51 0.1 - 185.8 (23.2)

Figure S29.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p25.1' versus 'YEARS_TO_BIRTH'

P value = 0.000276 (Wilcoxon-test), Q value = 0.0011

Table S30.  Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 9(3P25.1) MUTATED 80 68.5 (10.6)
AMP PEAK 9(3P25.1) WILD-TYPE 446 63.2 (11.2)

Figure S30.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S31.  Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 9(3P25.1) MUTATED 36 1 43
AMP PEAK 9(3P25.1) WILD-TYPE 359 20 69

Figure S31.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0992 (Fisher's exact test), Q value = 0.17

Table S32.  Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 9(3P25.1) MUTATED 15 65
AMP PEAK 9(3P25.1) WILD-TYPE 126 322

Figure S32.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3p25.1' versus 'RACE'

P value = 0.00328 (Fisher's exact test), Q value = 0.0097

Table S33.  Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 9(3P25.1) MUTATED 0 0 23 4 47
AMP PEAK 9(3P25.1) WILD-TYPE 4 20 78 5 319

Figure S33.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'Time to Death'

P value = 0.00125 (logrank test), Q value = 0.0042

Table S34.  Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 10(3P14.1) MUTATED 63 17 0.1 - 191.8 (27.2)
AMP PEAK 10(3P14.1) WILD-TYPE 463 52 0.1 - 185.8 (23.3)

Figure S34.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p14.1' versus 'YEARS_TO_BIRTH'

P value = 0.00377 (Wilcoxon-test), Q value = 0.011

Table S35.  Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 10(3P14.1) MUTATED 63 68.1 (10.3)
AMP PEAK 10(3P14.1) WILD-TYPE 463 63.5 (11.2)

Figure S35.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p14.1' versus 'HISTOLOGICAL_TYPE'

P value = 8e-05 (Fisher's exact test), Q value = 4e-04

Table S36.  Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 10(3P14.1) MUTATED 33 3 27
AMP PEAK 10(3P14.1) WILD-TYPE 362 18 85

Figure S36.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0476 (Fisher's exact test), Q value = 0.093

Table S37.  Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 10(3P14.1) MUTATED 10 53
AMP PEAK 10(3P14.1) WILD-TYPE 131 334

Figure S37.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3p14.1' versus 'RACE'

P value = 0.0109 (Fisher's exact test), Q value = 0.026

Table S38.  Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 10(3P14.1) MUTATED 1 0 15 4 39
AMP PEAK 10(3P14.1) WILD-TYPE 3 20 86 5 327

Figure S38.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'ETHNICITY'

P value = 0.0802 (Fisher's exact test), Q value = 0.15

Table S39.  Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
AMP PEAK 10(3P14.1) MUTATED 4 43
AMP PEAK 10(3P14.1) WILD-TYPE 10 324

Figure S39.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_3q26.2' versus 'Time to Death'

P value = 0.000911 (logrank test), Q value = 0.0033

Table S40.  Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 11(3Q26.2) MUTATED 171 34 0.1 - 191.8 (22.1)
AMP PEAK 11(3Q26.2) WILD-TYPE 355 35 0.2 - 185.8 (23.5)

Figure S40.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 2.54e-11 (Wilcoxon-test), Q value = 1.8e-08

Table S41.  Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 11(3Q26.2) MUTATED 170 68.4 (9.3)
AMP PEAK 11(3Q26.2) WILD-TYPE 356 61.9 (11.4)

Figure S41.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S42.  Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 11(3Q26.2) MUTATED 73 8 90
AMP PEAK 11(3Q26.2) WILD-TYPE 322 13 22

Figure S42.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0273 (Fisher's exact test), Q value = 0.058

Table S43.  Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 11(3Q26.2) MUTATED 35 136
AMP PEAK 11(3Q26.2) WILD-TYPE 106 251

Figure S43.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3q26.2' versus 'RACE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S44.  Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 11(3Q26.2) MUTATED 0 3 52 4 100
AMP PEAK 11(3Q26.2) WILD-TYPE 4 17 49 5 266

Figure S44.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_3q26.2' versus 'Time to Death'

P value = 0.00286 (logrank test), Q value = 0.0086

Table S45.  Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 12(3Q26.2) MUTATED 159 31 0.1 - 191.8 (22.1)
AMP PEAK 12(3Q26.2) WILD-TYPE 367 38 0.2 - 185.8 (23.5)

Figure S45.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 3.3e-09 (Wilcoxon-test), Q value = 4.6e-07

Table S46.  Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 12(3Q26.2) MUTATED 158 68.2 (9.4)
AMP PEAK 12(3Q26.2) WILD-TYPE 368 62.2 (11.5)

Figure S46.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S47.  Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 12(3Q26.2) MUTATED 65 7 87
AMP PEAK 12(3Q26.2) WILD-TYPE 330 14 25

Figure S47.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0533 (Fisher's exact test), Q value = 0.1

Table S48.  Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 12(3Q26.2) MUTATED 33 126
AMP PEAK 12(3Q26.2) WILD-TYPE 108 261

Figure S48.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3q26.2' versus 'RACE'

P value = 0.00015 (Fisher's exact test), Q value = 0.00069

Table S49.  Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 12(3Q26.2) MUTATED 0 3 48 4 93
AMP PEAK 12(3Q26.2) WILD-TYPE 4 17 53 5 273

Figure S49.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 2.74e-05 (Wilcoxon-test), Q value = 0.00015

Table S50.  Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 13(4P16.3) MUTATED 52 69.7 (9.0)
AMP PEAK 13(4P16.3) WILD-TYPE 474 63.4 (11.3)

Figure S50.  Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S51.  Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 13(4P16.3) MUTATED 15 1 36
AMP PEAK 13(4P16.3) WILD-TYPE 380 20 76

Figure S51.  Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'Time to Death'

P value = 0.000241 (logrank test), Q value = 0.001

Table S52.  Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 14(5P15.33) MUTATED 87 21 0.2 - 125.4 (20.8)
AMP PEAK 14(5P15.33) WILD-TYPE 439 48 0.1 - 191.8 (23.5)

Figure S52.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

'amp_5p15.33' versus 'YEARS_TO_BIRTH'

P value = 0.000107 (Wilcoxon-test), Q value = 5e-04

Table S53.  Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 14(5P15.33) MUTATED 88 67.7 (10.0)
AMP PEAK 14(5P15.33) WILD-TYPE 438 63.3 (11.3)

Figure S53.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5p15.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S54.  Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 14(5P15.33) MUTATED 30 3 55
AMP PEAK 14(5P15.33) WILD-TYPE 365 18 57

Figure S54.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.113 (Fisher's exact test), Q value = 0.19

Table S55.  Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 14(5P15.33) MUTATED 17 71
AMP PEAK 14(5P15.33) WILD-TYPE 124 316

Figure S55.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_5p15.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.133 (Fisher's exact test), Q value = 0.22

Table S56.  Gene #14: 'amp_5p15.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 14(5P15.33) MUTATED 57 3 6 8
AMP PEAK 14(5P15.33) WILD-TYPE 306 20 11 27

Figure S56.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_5p15.33' versus 'RACE'

P value = 0.00247 (Fisher's exact test), Q value = 0.0076

Table S57.  Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 14(5P15.33) MUTATED 1 2 30 2 49
AMP PEAK 14(5P15.33) WILD-TYPE 3 18 71 7 317

Figure S57.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

'amp_5q35.3' versus 'Time to Death'

P value = 0.00614 (logrank test), Q value = 0.016

Table S58.  Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 15(5Q35.3) MUTATED 52 11 0.4 - 96.7 (16.2)
AMP PEAK 15(5Q35.3) WILD-TYPE 474 58 0.1 - 191.8 (23.8)

Figure S58.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

'amp_5q35.3' versus 'YEARS_TO_BIRTH'

P value = 0.000282 (Wilcoxon-test), Q value = 0.0011

Table S59.  Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 15(5Q35.3) MUTATED 53 69.3 (10.3)
AMP PEAK 15(5Q35.3) WILD-TYPE 473 63.4 (11.2)

Figure S59.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5q35.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S60.  Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 15(5Q35.3) MUTATED 20 2 31
AMP PEAK 15(5Q35.3) WILD-TYPE 375 19 81

Figure S60.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5q35.3' versus 'RACE'

P value = 0.0197 (Fisher's exact test), Q value = 0.044

Table S61.  Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 15(5Q35.3) MUTATED 0 1 20 0 30
AMP PEAK 15(5Q35.3) WILD-TYPE 4 19 81 9 336

Figure S61.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

'amp_6p24.2' versus 'Time to Death'

P value = 0.0559 (logrank test), Q value = 0.11

Table S62.  Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 16(6P24.2) MUTATED 114 22 0.1 - 125.4 (27.3)
AMP PEAK 16(6P24.2) WILD-TYPE 412 47 0.2 - 191.8 (22.7)

Figure S62.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_6p24.2' versus 'YEARS_TO_BIRTH'

P value = 2.5e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S63.  Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 16(6P24.2) MUTATED 114 68.1 (9.9)
AMP PEAK 16(6P24.2) WILD-TYPE 412 62.9 (11.3)

Figure S63.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S64.  Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 16(6P24.2) MUTATED 45 5 64
AMP PEAK 16(6P24.2) WILD-TYPE 350 16 48

Figure S64.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6p24.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0937 (Fisher's exact test), Q value = 0.16

Table S65.  Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 16(6P24.2) MUTATED 23 91
AMP PEAK 16(6P24.2) WILD-TYPE 118 296

Figure S65.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_6p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.000195 (Wilcoxon-test), Q value = 0.00086

Table S66.  Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 17(6P22.3) MUTATED 104 67.4 (9.9)
AMP PEAK 17(6P22.3) WILD-TYPE 422 63.2 (11.4)

Figure S66.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S67.  Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 17(6P22.3) MUTATED 40 4 60
AMP PEAK 17(6P22.3) WILD-TYPE 355 17 52

Figure S67.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6p22.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.108 (Fisher's exact test), Q value = 0.18

Table S68.  Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 17(6P22.3) MUTATED 21 83
AMP PEAK 17(6P22.3) WILD-TYPE 120 304

Figure S68.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_6p22.3' versus 'RACE'

P value = 0.00738 (Fisher's exact test), Q value = 0.019

Table S69.  Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 17(6P22.3) MUTATED 0 2 33 2 62
AMP PEAK 17(6P22.3) WILD-TYPE 4 18 68 7 304

Figure S69.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

'amp_6q25.1' versus 'Time to Death'

P value = 0.0921 (logrank test), Q value = 0.16

Table S70.  Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 18(6Q25.1) MUTATED 84 15 0.1 - 97.7 (22.8)
AMP PEAK 18(6Q25.1) WILD-TYPE 442 54 0.2 - 191.8 (23.4)

Figure S70.  Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_6q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.00172 (Wilcoxon-test), Q value = 0.0055

Table S71.  Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 18(6Q25.1) MUTATED 84 67.0 (10.5)
AMP PEAK 18(6Q25.1) WILD-TYPE 442 63.4 (11.3)

Figure S71.  Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S72.  Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 18(6Q25.1) MUTATED 44 2 38
AMP PEAK 18(6Q25.1) WILD-TYPE 351 19 74

Figure S72.  Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6q25.1' versus 'RACE'

P value = 0.00526 (Fisher's exact test), Q value = 0.014

Table S73.  Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 18(6Q25.1) MUTATED 0 1 28 2 48
AMP PEAK 18(6Q25.1) WILD-TYPE 4 19 73 7 318

Figure S73.  Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

'amp_7q31.2' versus 'Time to Death'

P value = 8.52e-07 (logrank test), Q value = 2.7e-05

Table S74.  Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 19(7Q31.2) MUTATED 89 23 0.2 - 125.4 (16.9)
AMP PEAK 19(7Q31.2) WILD-TYPE 437 46 0.1 - 191.8 (24.4)

Figure S74.  Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

'amp_7q31.2' versus 'YEARS_TO_BIRTH'

P value = 0.0795 (Wilcoxon-test), Q value = 0.14

Table S75.  Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 19(7Q31.2) MUTATED 89 65.9 (11.9)
AMP PEAK 19(7Q31.2) WILD-TYPE 437 63.6 (11.1)

Figure S75.  Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_7q31.2' versus 'HISTOLOGICAL_TYPE'

P value = 7e-05 (Fisher's exact test), Q value = 0.00036

Table S76.  Gene #19: 'amp_7q31.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 19(7Q31.2) MUTATED 51 5 34
AMP PEAK 19(7Q31.2) WILD-TYPE 344 16 78

Figure S76.  Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_7q31.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0184 (Fisher's exact test), Q value = 0.041

Table S77.  Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 19(7Q31.2) MUTATED 15 75
AMP PEAK 19(7Q31.2) WILD-TYPE 126 312

Figure S77.  Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8p11.22' versus 'Time to Death'

P value = 0.00209 (logrank test), Q value = 0.0065

Table S78.  Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 20(8P11.22) MUTATED 125 25 0.1 - 118.0 (19.6)
AMP PEAK 20(8P11.22) WILD-TYPE 401 44 0.1 - 191.8 (24.0)

Figure S78.  Get High-res Image Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'Time to Death'

P value = 1.13e-05 (logrank test), Q value = 6.6e-05

Table S79.  Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 21(8P11.21) MUTATED 161 35 0.1 - 125.4 (19.4)
AMP PEAK 21(8P11.21) WILD-TYPE 365 34 0.2 - 191.8 (25.0)

Figure S79.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S80.  Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 21(8P11.21) MUTATED 94 7 60
AMP PEAK 21(8P11.21) WILD-TYPE 301 14 52

Figure S80.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8p11.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.019 (Fisher's exact test), Q value = 0.042

Table S81.  Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 21(8P11.21) MUTATED 32 129
AMP PEAK 21(8P11.21) WILD-TYPE 109 258

Figure S81.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8p11.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00642 (Fisher's exact test), Q value = 0.017

Table S82.  Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 21(8P11.21) MUTATED 106 4 11 14
AMP PEAK 21(8P11.21) WILD-TYPE 257 19 6 21

Figure S82.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_8q24.21' versus 'Time to Death'

P value = 0.000217 (logrank test), Q value = 0.00092

Table S83.  Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 22(8Q24.21) MUTATED 204 40 0.1 - 191.8 (20.7)
AMP PEAK 22(8Q24.21) WILD-TYPE 322 29 0.2 - 185.8 (24.8)

Figure S83.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.0412 (Wilcoxon-test), Q value = 0.083

Table S84.  Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 22(8Q24.21) MUTATED 204 64.8 (11.7)
AMP PEAK 22(8Q24.21) WILD-TYPE 322 63.5 (10.9)

Figure S84.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S85.  Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 22(8Q24.21) MUTATED 116 10 80
AMP PEAK 22(8Q24.21) WILD-TYPE 279 11 32

Figure S85.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00478 (Fisher's exact test), Q value = 0.013

Table S86.  Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 22(8Q24.21) MUTATED 41 165
AMP PEAK 22(8Q24.21) WILD-TYPE 100 222

Figure S86.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8q24.21' versus 'Time to Death'

P value = 0.000397 (logrank test), Q value = 0.0015

Table S87.  Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 23(8Q24.21) MUTATED 210 40 0.1 - 191.8 (20.7)
AMP PEAK 23(8Q24.21) WILD-TYPE 316 29 0.2 - 185.8 (25.0)

Figure S87.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.0149 (Wilcoxon-test), Q value = 0.034

Table S88.  Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 23(8Q24.21) MUTATED 210 65.1 (11.6)
AMP PEAK 23(8Q24.21) WILD-TYPE 316 63.3 (10.9)

Figure S88.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S89.  Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 23(8Q24.21) MUTATED 119 9 84
AMP PEAK 23(8Q24.21) WILD-TYPE 276 12 28

Figure S89.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00359 (Fisher's exact test), Q value = 0.01

Table S90.  Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 23(8Q24.21) MUTATED 42 170
AMP PEAK 23(8Q24.21) WILD-TYPE 99 217

Figure S90.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8q24.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0114 (Fisher's exact test), Q value = 0.028

Table S91.  Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 23(8Q24.21) MUTATED 143 6 13 14
AMP PEAK 23(8Q24.21) WILD-TYPE 220 17 4 21

Figure S91.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_9p24.2' versus 'Time to Death'

P value = 0.0302 (logrank test), Q value = 0.062

Table S92.  Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 24(9P24.2) MUTATED 63 14 0.1 - 125.4 (24.0)
AMP PEAK 24(9P24.2) WILD-TYPE 463 55 0.1 - 191.8 (23.3)

Figure S92.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_9p24.2' versus 'YEARS_TO_BIRTH'

P value = 0.00194 (Wilcoxon-test), Q value = 0.0061

Table S93.  Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 24(9P24.2) MUTATED 64 67.4 (9.2)
AMP PEAK 24(9P24.2) WILD-TYPE 462 63.5 (11.4)

Figure S93.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S94.  Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 24(9P24.2) MUTATED 25 3 36
AMP PEAK 24(9P24.2) WILD-TYPE 370 18 76

Figure S94.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_9p24.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S95.  Gene #24: 'amp_9p24.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 24(9P24.2) MUTATED 39 3 3 8
AMP PEAK 24(9P24.2) WILD-TYPE 324 20 14 27

Figure S95.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_9p24.2' versus 'ETHNICITY'

P value = 0.0214 (Fisher's exact test), Q value = 0.047

Table S96.  Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
AMP PEAK 24(9P24.2) MUTATED 5 43
AMP PEAK 24(9P24.2) WILD-TYPE 9 324

Figure S96.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

'amp_9q34.3' versus 'Time to Death'

P value = 0.0429 (logrank test), Q value = 0.086

Table S97.  Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 25(9Q34.3) MUTATED 38 8 0.1 - 71.2 (20.1)
AMP PEAK 25(9Q34.3) WILD-TYPE 488 61 0.1 - 191.8 (23.4)

Figure S97.  Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

'amp_9q34.3' versus 'YEARS_TO_BIRTH'

P value = 0.00159 (Wilcoxon-test), Q value = 0.0052

Table S98.  Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 25(9Q34.3) MUTATED 38 69.3 (8.1)
AMP PEAK 25(9Q34.3) WILD-TYPE 488 63.6 (11.3)

Figure S98.  Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S99.  Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 25(9Q34.3) MUTATED 13 4 21
AMP PEAK 25(9Q34.3) WILD-TYPE 382 17 91

Figure S99.  Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_9q34.3' versus 'RACE'

P value = 0.00983 (Fisher's exact test), Q value = 0.024

Table S100.  Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 25(9Q34.3) MUTATED 0 1 17 0 20
AMP PEAK 25(9Q34.3) WILD-TYPE 4 19 84 9 346

Figure S100.  Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

'amp_10q22.2' versus 'Time to Death'

P value = 0.0931 (logrank test), Q value = 0.16

Table S101.  Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 26(10Q22.2) MUTATED 142 24 0.6 - 185.8 (22.8)
AMP PEAK 26(10Q22.2) WILD-TYPE 384 45 0.1 - 191.8 (23.4)

Figure S101.  Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

'amp_10q22.2' versus 'HISTOLOGICAL_TYPE'

P value = 0.00337 (Fisher's exact test), Q value = 0.0099

Table S102.  Gene #26: 'amp_10q22.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 26(10Q22.2) MUTATED 96 3 44
AMP PEAK 26(10Q22.2) WILD-TYPE 299 18 68

Figure S102.  Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11p11.2' versus 'Time to Death'

P value = 0.00175 (logrank test), Q value = 0.0056

Table S103.  Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 27(11P11.2) MUTATED 50 13 1.4 - 110.1 (20.1)
AMP PEAK 27(11P11.2) WILD-TYPE 476 56 0.1 - 191.8 (23.6)

Figure S103.  Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_11p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000211 (Wilcoxon-test), Q value = 9e-04

Table S104.  Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 27(11P11.2) MUTATED 50 69.7 (9.5)
AMP PEAK 27(11P11.2) WILD-TYPE 476 63.4 (11.2)

Figure S104.  Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S105.  Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 27(11P11.2) MUTATED 16 4 30
AMP PEAK 27(11P11.2) WILD-TYPE 379 17 82

Figure S105.  Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q13.2' versus 'Time to Death'

P value = 0.00465 (logrank test), Q value = 0.013

Table S106.  Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 28(11Q13.2) MUTATED 70 16 0.1 - 80.4 (24.0)
AMP PEAK 28(11Q13.2) WILD-TYPE 456 53 0.1 - 191.8 (23.3)

Figure S106.  Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

'amp_11q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.000622 (Wilcoxon-test), Q value = 0.0023

Table S107.  Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 28(11Q13.2) MUTATED 70 68.1 (9.9)
AMP PEAK 28(11Q13.2) WILD-TYPE 456 63.4 (11.3)

Figure S107.  Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S108.  Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 28(11Q13.2) MUTATED 33 3 34
AMP PEAK 28(11Q13.2) WILD-TYPE 362 18 78

Figure S108.  Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q14.1' versus 'Time to Death'

P value = 5.34e-07 (logrank test), Q value = 2e-05

Table S109.  Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 29(11Q14.1) MUTATED 56 18 0.4 - 102.3 (20.4)
AMP PEAK 29(11Q14.1) WILD-TYPE 470 51 0.1 - 191.8 (23.6)

Figure S109.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

'amp_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.0108 (Wilcoxon-test), Q value = 0.026

Table S110.  Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 29(11Q14.1) MUTATED 56 67.7 (10.7)
AMP PEAK 29(11Q14.1) WILD-TYPE 470 63.6 (11.2)

Figure S110.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S111.  Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 29(11Q14.1) MUTATED 21 1 34
AMP PEAK 29(11Q14.1) WILD-TYPE 374 20 78

Figure S111.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.15 (Fisher's exact test), Q value = 0.24

Table S112.  Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 29(11Q14.1) MUTATED 10 46
AMP PEAK 29(11Q14.1) WILD-TYPE 131 341

Figure S112.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_11q14.1' versus 'RACE'

P value = 0.101 (Fisher's exact test), Q value = 0.18

Table S113.  Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 29(11Q14.1) MUTATED 1 0 16 1 35
AMP PEAK 29(11Q14.1) WILD-TYPE 3 20 85 8 331

Figure S113.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'YEARS_TO_BIRTH'

P value = 0.145 (Wilcoxon-test), Q value = 0.23

Table S114.  Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 30(12P12.1) MUTATED 91 65.4 (11.5)
AMP PEAK 30(12P12.1) WILD-TYPE 435 63.7 (11.2)

Figure S114.  Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S115.  Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 30(12P12.1) MUTATED 44 4 44
AMP PEAK 30(12P12.1) WILD-TYPE 351 17 68

Figure S115.  Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12p12.1' versus 'RACE'

P value = 0.117 (Fisher's exact test), Q value = 0.2

Table S116.  Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 30(12P12.1) MUTATED 0 6 24 2 56
AMP PEAK 30(12P12.1) WILD-TYPE 4 14 77 7 310

Figure S116.  Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'ETHNICITY'

P value = 0.145 (Fisher's exact test), Q value = 0.23

Table S117.  Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
AMP PEAK 30(12P12.1) MUTATED 0 68
AMP PEAK 30(12P12.1) WILD-TYPE 14 299

Figure S117.  Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_12q13.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S118.  Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 31(12Q13.11) MUTATED 39 4 41
AMP PEAK 31(12Q13.11) WILD-TYPE 356 17 71

Figure S118.  Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12q13.11' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S119.  Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 31(12Q13.11) MUTATED 16 68
AMP PEAK 31(12Q13.11) WILD-TYPE 125 319

Figure S119.  Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_12q13.11' versus 'RACE'

P value = 0.0178 (Fisher's exact test), Q value = 0.04

Table S120.  Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 31(12Q13.11) MUTATED 1 6 23 3 49
AMP PEAK 31(12Q13.11) WILD-TYPE 3 14 78 6 317

Figure S120.  Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

'amp_12q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.113 (Wilcoxon-test), Q value = 0.19

Table S121.  Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 32(12Q13.2) MUTATED 97 65.4 (11.7)
AMP PEAK 32(12Q13.2) WILD-TYPE 429 63.7 (11.1)

Figure S121.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S122.  Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 32(12Q13.2) MUTATED 49 4 44
AMP PEAK 32(12Q13.2) WILD-TYPE 346 17 68

Figure S122.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12q13.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0561 (Fisher's exact test), Q value = 0.11

Table S123.  Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 32(12Q13.2) MUTATED 18 79
AMP PEAK 32(12Q13.2) WILD-TYPE 123 308

Figure S123.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_12q13.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.124 (Fisher's exact test), Q value = 0.21

Table S124.  Gene #32: 'amp_12q13.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 32(12Q13.2) MUTATED 69 3 7 5
AMP PEAK 32(12Q13.2) WILD-TYPE 294 20 10 30

Figure S124.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_12q13.2' versus 'RACE'

P value = 0.124 (Fisher's exact test), Q value = 0.21

Table S125.  Gene #32: 'amp_12q13.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 32(12Q13.2) MUTATED 1 6 25 2 59
AMP PEAK 32(12Q13.2) WILD-TYPE 3 14 76 7 307

Figure S125.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #6: 'RACE'

'amp_13q34' versus 'YEARS_TO_BIRTH'

P value = 8.49e-05 (Wilcoxon-test), Q value = 0.00042

Table S126.  Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 33(13Q34) MUTATED 57 69.1 (7.4)
AMP PEAK 33(13Q34) WILD-TYPE 469 63.4 (11.4)

Figure S126.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_13q34' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S127.  Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 33(13Q34) MUTATED 14 4 39
AMP PEAK 33(13Q34) WILD-TYPE 381 17 73

Figure S127.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_13q34' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0141 (Fisher's exact test), Q value = 0.033

Table S128.  Gene #33: 'amp_13q34' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 33(13Q34) MUTATED 34 6 4 6
AMP PEAK 33(13Q34) WILD-TYPE 329 17 13 29

Figure S128.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_13q34' versus 'RACE'

P value = 0.0622 (Fisher's exact test), Q value = 0.12

Table S129.  Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 33(13Q34) MUTATED 0 2 18 2 32
AMP PEAK 33(13Q34) WILD-TYPE 4 18 83 7 334

Figure S129.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

'amp_14q24.3' versus 'Time to Death'

P value = 0.000162 (logrank test), Q value = 0.00074

Table S130.  Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 34(14Q24.3) MUTATED 63 19 0.4 - 125.4 (23.7)
AMP PEAK 34(14Q24.3) WILD-TYPE 463 50 0.1 - 191.8 (23.3)

Figure S130.  Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

'amp_14q24.3' versus 'YEARS_TO_BIRTH'

P value = 0.00117 (Wilcoxon-test), Q value = 0.004

Table S131.  Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 34(14Q24.3) MUTATED 63 68.1 (9.0)
AMP PEAK 34(14Q24.3) WILD-TYPE 463 63.5 (11.4)

Figure S131.  Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S132.  Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 34(14Q24.3) MUTATED 21 4 38
AMP PEAK 34(14Q24.3) WILD-TYPE 374 17 74

Figure S132.  Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'Time to Death'

P value = 0.00433 (logrank test), Q value = 0.012

Table S133.  Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 35(14Q32.33) MUTATED 75 18 0.3 - 110.1 (23.9)
AMP PEAK 35(14Q32.33) WILD-TYPE 451 51 0.1 - 191.8 (23.3)

Figure S133.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

'amp_14q32.33' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S134.  Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 35(14Q32.33) MUTATED 76 67.6 (9.2)
AMP PEAK 35(14Q32.33) WILD-TYPE 450 63.4 (11.4)

Figure S134.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q32.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S135.  Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 35(14Q32.33) MUTATED 30 5 41
AMP PEAK 35(14Q32.33) WILD-TYPE 365 16 71

Figure S135.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00784 (Fisher's exact test), Q value = 0.02

Table S136.  Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 35(14Q32.33) MUTATED 11 65
AMP PEAK 35(14Q32.33) WILD-TYPE 130 322

Figure S136.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_14q32.33' versus 'RACE'

P value = 0.0198 (Fisher's exact test), Q value = 0.044

Table S137.  Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 35(14Q32.33) MUTATED 0 0 23 2 46
AMP PEAK 35(14Q32.33) WILD-TYPE 4 20 78 7 320

Figure S137.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

'amp_15q26.3' versus 'Time to Death'

P value = 0.00146 (logrank test), Q value = 0.0048

Table S138.  Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 36(15Q26.3) MUTATED 37 12 1.7 - 110.1 (28.1)
AMP PEAK 36(15Q26.3) WILD-TYPE 489 57 0.1 - 191.8 (23.3)

Figure S138.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

'amp_15q26.3' versus 'YEARS_TO_BIRTH'

P value = 0.00329 (Wilcoxon-test), Q value = 0.0097

Table S139.  Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 36(15Q26.3) MUTATED 37 68.9 (11.2)
AMP PEAK 36(15Q26.3) WILD-TYPE 489 63.6 (11.1)

Figure S139.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_15q26.3' versus 'HISTOLOGICAL_TYPE'

P value = 9e-05 (Fisher's exact test), Q value = 0.00043

Table S140.  Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 36(15Q26.3) MUTATED 17 1 19
AMP PEAK 36(15Q26.3) WILD-TYPE 378 20 93

Figure S140.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_15q26.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.081 (Fisher's exact test), Q value = 0.15

Table S141.  Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 36(15Q26.3) MUTATED 5 32
AMP PEAK 36(15Q26.3) WILD-TYPE 136 355

Figure S141.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_15q26.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0122 (Fisher's exact test), Q value = 0.029

Table S142.  Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 36(15Q26.3) MUTATED 20 3 4 4
AMP PEAK 36(15Q26.3) WILD-TYPE 343 20 13 31

Figure S142.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_16p11.2' versus 'Time to Death'

P value = 0.0156 (logrank test), Q value = 0.036

Table S143.  Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 37(16P11.2) MUTATED 64 14 0.1 - 102.3 (22.0)
AMP PEAK 37(16P11.2) WILD-TYPE 462 55 0.1 - 191.8 (23.4)

Figure S143.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_16p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000343 (Wilcoxon-test), Q value = 0.0013

Table S144.  Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 37(16P11.2) MUTATED 64 68.3 (8.9)
AMP PEAK 37(16P11.2) WILD-TYPE 462 63.4 (11.4)

Figure S144.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_16p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S145.  Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 37(16P11.2) MUTATED 22 2 40
AMP PEAK 37(16P11.2) WILD-TYPE 373 19 72

Figure S145.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_16p11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0732 (Fisher's exact test), Q value = 0.13

Table S146.  Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 37(16P11.2) MUTATED 40 3 3 9
AMP PEAK 37(16P11.2) WILD-TYPE 323 20 14 26

Figure S146.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_16p11.2' versus 'RACE'

P value = 0.0954 (Fisher's exact test), Q value = 0.17

Table S147.  Gene #37: 'amp_16p11.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 37(16P11.2) MUTATED 0 2 20 1 36
AMP PEAK 37(16P11.2) WILD-TYPE 4 18 81 8 330

Figure S147.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #6: 'RACE'

'amp_17q11.2' versus 'Time to Death'

P value = 0.00184 (logrank test), Q value = 0.0059

Table S148.  Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 38(17Q11.2) MUTATED 71 16 0.1 - 110.1 (17.6)
AMP PEAK 38(17Q11.2) WILD-TYPE 455 53 0.1 - 191.8 (23.6)

Figure S148.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.00579 (Wilcoxon-test), Q value = 0.015

Table S149.  Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 38(17Q11.2) MUTATED 70 67.5 (8.6)
AMP PEAK 38(17Q11.2) WILD-TYPE 456 63.5 (11.5)

Figure S149.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S150.  Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 38(17Q11.2) MUTATED 19 6 46
AMP PEAK 38(17Q11.2) WILD-TYPE 376 15 66

Figure S150.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00113 (Fisher's exact test), Q value = 0.0039

Table S151.  Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 38(17Q11.2) MUTATED 39 7 6 7
AMP PEAK 38(17Q11.2) WILD-TYPE 324 16 11 28

Figure S151.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_17q11.2' versus 'RACE'

P value = 0.00234 (Fisher's exact test), Q value = 0.0072

Table S152.  Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 38(17Q11.2) MUTATED 1 1 25 2 38
AMP PEAK 38(17Q11.2) WILD-TYPE 3 19 76 7 328

Figure S152.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

'amp_17q12' versus 'Time to Death'

P value = 0.000384 (logrank test), Q value = 0.0015

Table S153.  Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 39(17Q12) MUTATED 74 18 0.1 - 110.1 (20.4)
AMP PEAK 39(17Q12) WILD-TYPE 452 51 0.1 - 191.8 (23.5)

Figure S153.  Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

'amp_17q12' versus 'YEARS_TO_BIRTH'

P value = 0.0027 (Wilcoxon-test), Q value = 0.0081

Table S154.  Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 39(17Q12) MUTATED 73 68.0 (9.2)
AMP PEAK 39(17Q12) WILD-TYPE 453 63.4 (11.4)

Figure S154.  Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S155.  Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 39(17Q12) MUTATED 20 3 51
AMP PEAK 39(17Q12) WILD-TYPE 375 18 61

Figure S155.  Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q12' versus 'RACE'

P value = 0.0053 (Fisher's exact test), Q value = 0.014

Table S156.  Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 39(17Q12) MUTATED 1 0 25 0 47
AMP PEAK 39(17Q12) WILD-TYPE 3 20 76 9 319

Figure S156.  Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

'amp_17q25.1' versus 'Time to Death'

P value = 0.000212 (logrank test), Q value = 9e-04

Table S157.  Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 40(17Q25.1) MUTATED 102 24 0.1 - 125.4 (21.4)
AMP PEAK 40(17Q25.1) WILD-TYPE 424 45 0.1 - 191.8 (23.8)

Figure S157.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_17q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S158.  Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 40(17Q25.1) MUTATED 101 67.3 (9.2)
AMP PEAK 40(17Q25.1) WILD-TYPE 425 63.2 (11.5)

Figure S158.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S159.  Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 40(17Q25.1) MUTATED 37 9 56
AMP PEAK 40(17Q25.1) WILD-TYPE 358 12 56

Figure S159.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q25.1' versus 'RACE'

P value = 8e-05 (Fisher's exact test), Q value = 4e-04

Table S160.  Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 40(17Q25.1) MUTATED 0 0 36 2 59
AMP PEAK 40(17Q25.1) WILD-TYPE 4 20 65 7 307

Figure S160.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

'amp_18p11.31' versus 'Time to Death'

P value = 0.00693 (logrank test), Q value = 0.018

Table S161.  Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 41(18P11.31) MUTATED 94 21 0.4 - 125.4 (23.8)
AMP PEAK 41(18P11.31) WILD-TYPE 432 48 0.1 - 191.8 (23.3)

Figure S161.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

'amp_18p11.31' versus 'YEARS_TO_BIRTH'

P value = 8.63e-05 (Wilcoxon-test), Q value = 0.00042

Table S162.  Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 41(18P11.31) MUTATED 93 67.9 (9.1)
AMP PEAK 41(18P11.31) WILD-TYPE 433 63.2 (11.5)

Figure S162.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18p11.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S163.  Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 41(18P11.31) MUTATED 29 6 59
AMP PEAK 41(18P11.31) WILD-TYPE 366 15 53

Figure S163.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_18p11.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0204 (Fisher's exact test), Q value = 0.045

Table S164.  Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 41(18P11.31) MUTATED 16 78
AMP PEAK 41(18P11.31) WILD-TYPE 125 309

Figure S164.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_18p11.31' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0266 (Fisher's exact test), Q value = 0.057

Table S165.  Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 41(18P11.31) MUTATED 61 3 8 7
AMP PEAK 41(18P11.31) WILD-TYPE 302 20 9 28

Figure S165.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_18p11.31' versus 'RACE'

P value = 0.00112 (Fisher's exact test), Q value = 0.0039

Table S166.  Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 41(18P11.31) MUTATED 0 3 33 1 52
AMP PEAK 41(18P11.31) WILD-TYPE 4 17 68 8 314

Figure S166.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

'amp_18q11.2' versus 'Time to Death'

P value = 0.00841 (logrank test), Q value = 0.021

Table S167.  Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 42(18Q11.2) MUTATED 68 17 1.4 - 125.4 (27.1)
AMP PEAK 42(18Q11.2) WILD-TYPE 458 52 0.1 - 191.8 (22.9)

Figure S167.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_18q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.00197 (Wilcoxon-test), Q value = 0.0062

Table S168.  Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 42(18Q11.2) MUTATED 67 67.9 (10.1)
AMP PEAK 42(18Q11.2) WILD-TYPE 459 63.4 (11.3)

Figure S168.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S169.  Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 42(18Q11.2) MUTATED 20 4 44
AMP PEAK 42(18Q11.2) WILD-TYPE 375 17 68

Figure S169.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_18q11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0755 (Fisher's exact test), Q value = 0.14

Table S170.  Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 42(18Q11.2) MUTATED 43 1 4 8
AMP PEAK 42(18Q11.2) WILD-TYPE 320 22 13 27

Figure S170.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_18q11.2' versus 'RACE'

P value = 0.00519 (Fisher's exact test), Q value = 0.014

Table S171.  Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 42(18Q11.2) MUTATED 0 1 25 1 38
AMP PEAK 42(18Q11.2) WILD-TYPE 4 19 76 8 328

Figure S171.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

'amp_19p13.2' versus 'Time to Death'

P value = 0.0128 (logrank test), Q value = 0.03

Table S172.  Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 43(19P13.2) MUTATED 96 20 0.1 - 125.4 (23.1)
AMP PEAK 43(19P13.2) WILD-TYPE 430 49 0.1 - 191.8 (23.3)

Figure S172.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

'amp_19p13.2' versus 'YEARS_TO_BIRTH'

P value = 4.56e-10 (Wilcoxon-test), Q value = 9.4e-08

Table S173.  Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 43(19P13.2) MUTATED 96 70.2 (8.6)
AMP PEAK 43(19P13.2) WILD-TYPE 430 62.6 (11.3)

Figure S173.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19p13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S174.  Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 43(19P13.2) MUTATED 26 7 64
AMP PEAK 43(19P13.2) WILD-TYPE 369 14 48

Figure S174.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_19p13.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0561 (Fisher's exact test), Q value = 0.11

Table S175.  Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 43(19P13.2) MUTATED 18 79
AMP PEAK 43(19P13.2) WILD-TYPE 123 308

Figure S175.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_19p13.2' versus 'RACE'

P value = 0.00133 (Fisher's exact test), Q value = 0.0044

Table S176.  Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 43(19P13.2) MUTATED 0 0 31 2 58
AMP PEAK 43(19P13.2) WILD-TYPE 4 20 70 7 308

Figure S176.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

'amp_19q12' versus 'Time to Death'

P value = 4.99e-05 (logrank test), Q value = 0.00026

Table S177.  Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 44(19Q12) MUTATED 115 27 0.1 - 125.4 (20.5)
AMP PEAK 44(19Q12) WILD-TYPE 411 42 0.2 - 191.8 (23.9)

Figure S177.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

'amp_19q12' versus 'YEARS_TO_BIRTH'

P value = 1.44e-08 (Wilcoxon-test), Q value = 1e-06

Table S178.  Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 44(19Q12) MUTATED 115 68.9 (8.6)
AMP PEAK 44(19Q12) WILD-TYPE 411 62.6 (11.5)

Figure S178.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S179.  Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 44(19Q12) MUTATED 29 10 77
AMP PEAK 44(19Q12) WILD-TYPE 366 11 35

Figure S179.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_19q12' versus 'RACE'

P value = 3e-05 (Fisher's exact test), Q value = 0.00016

Table S180.  Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 44(19Q12) MUTATED 1 2 43 3 62
AMP PEAK 44(19Q12) WILD-TYPE 3 18 58 6 304

Figure S180.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

'amp_20p13' versus 'YEARS_TO_BIRTH'

P value = 2.37e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S181.  Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 45(20P13) MUTATED 116 67.8 (10.8)
AMP PEAK 45(20P13) WILD-TYPE 410 62.9 (11.1)

Figure S181.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20p13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S182.  Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 45(20P13) MUTATED 52 5 59
AMP PEAK 45(20P13) WILD-TYPE 343 16 53

Figure S182.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20p13' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.033 (Fisher's exact test), Q value = 0.068

Table S183.  Gene #45: 'amp_20p13' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 45(20P13) MUTATED 22 94
AMP PEAK 45(20P13) WILD-TYPE 119 293

Figure S183.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20p13' versus 'RACE'

P value = 0.0445 (Fisher's exact test), Q value = 0.088

Table S184.  Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 45(20P13) MUTATED 0 4 33 2 69
AMP PEAK 45(20P13) WILD-TYPE 4 16 68 7 297

Figure S184.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

'amp_20q11.21' versus 'Time to Death'

P value = 0.000289 (logrank test), Q value = 0.0012

Table S185.  Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 46(20Q11.21) MUTATED 148 31 0.1 - 149.6 (20.4)
AMP PEAK 46(20Q11.21) WILD-TYPE 378 38 0.1 - 191.8 (23.8)

Figure S185.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

'amp_20q11.21' versus 'YEARS_TO_BIRTH'

P value = 1.88e-08 (Wilcoxon-test), Q value = 1.2e-06

Table S186.  Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 46(20Q11.21) MUTATED 149 68.1 (9.7)
AMP PEAK 46(20Q11.21) WILD-TYPE 377 62.4 (11.4)

Figure S186.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S187.  Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 46(20Q11.21) MUTATED 62 6 81
AMP PEAK 46(20Q11.21) WILD-TYPE 333 15 31

Figure S187.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q11.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00612 (Fisher's exact test), Q value = 0.016

Table S188.  Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 46(20Q11.21) MUTATED 27 122
AMP PEAK 46(20Q11.21) WILD-TYPE 114 265

Figure S188.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q11.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S189.  Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 46(20Q11.21) MUTATED 93 5 9 10
AMP PEAK 46(20Q11.21) WILD-TYPE 270 18 8 25

Figure S189.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q11.21' versus 'RACE'

P value = 0.00654 (Fisher's exact test), Q value = 0.017

Table S190.  Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 46(20Q11.21) MUTATED 1 5 43 3 88
AMP PEAK 46(20Q11.21) WILD-TYPE 3 15 58 6 278

Figure S190.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

'amp_20q13.12' versus 'Time to Death'

P value = 0.00947 (logrank test), Q value = 0.023

Table S191.  Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 47(20Q13.12) MUTATED 148 28 0.1 - 191.8 (20.4)
AMP PEAK 47(20Q13.12) WILD-TYPE 378 41 0.1 - 185.8 (23.7)

Figure S191.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.12' versus 'YEARS_TO_BIRTH'

P value = 1.34e-08 (Wilcoxon-test), Q value = 1e-06

Table S192.  Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 47(20Q13.12) MUTATED 148 68.3 (10.0)
AMP PEAK 47(20Q13.12) WILD-TYPE 378 62.3 (11.2)

Figure S192.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S193.  Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 47(20Q13.12) MUTATED 64 7 78
AMP PEAK 47(20Q13.12) WILD-TYPE 331 14 34

Figure S193.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q13.12' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00104 (Fisher's exact test), Q value = 0.0037

Table S194.  Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 47(20Q13.12) MUTATED 25 124
AMP PEAK 47(20Q13.12) WILD-TYPE 116 263

Figure S194.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q13.12' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0596 (Fisher's exact test), Q value = 0.11

Table S195.  Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 47(20Q13.12) MUTATED 91 7 9 12
AMP PEAK 47(20Q13.12) WILD-TYPE 272 16 8 23

Figure S195.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q13.12' versus 'RACE'

P value = 0.00522 (Fisher's exact test), Q value = 0.014

Table S196.  Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 47(20Q13.12) MUTATED 1 5 43 3 87
AMP PEAK 47(20Q13.12) WILD-TYPE 3 15 58 6 279

Figure S196.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

'amp_20q13.33' versus 'Time to Death'

P value = 0.014 (logrank test), Q value = 0.033

Table S197.  Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 48(20Q13.33) MUTATED 149 28 0.1 - 191.8 (20.3)
AMP PEAK 48(20Q13.33) WILD-TYPE 377 41 0.1 - 185.8 (23.9)

Figure S197.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.33' versus 'YEARS_TO_BIRTH'

P value = 3.51e-08 (Wilcoxon-test), Q value = 1.8e-06

Table S198.  Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 48(20Q13.33) MUTATED 149 68.1 (10.3)
AMP PEAK 48(20Q13.33) WILD-TYPE 377 62.4 (11.2)

Figure S198.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S199.  Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 48(20Q13.33) MUTATED 67 6 77
AMP PEAK 48(20Q13.33) WILD-TYPE 328 15 35

Figure S199.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q13.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00101 (Fisher's exact test), Q value = 0.0036

Table S200.  Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 48(20Q13.33) MUTATED 25 125
AMP PEAK 48(20Q13.33) WILD-TYPE 116 262

Figure S200.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q13.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0133 (Fisher's exact test), Q value = 0.031

Table S201.  Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 48(20Q13.33) MUTATED 91 7 10 13
AMP PEAK 48(20Q13.33) WILD-TYPE 272 16 7 22

Figure S201.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q13.33' versus 'RACE'

P value = 0.0395 (Fisher's exact test), Q value = 0.081

Table S202.  Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 48(20Q13.33) MUTATED 1 6 41 3 92
AMP PEAK 48(20Q13.33) WILD-TYPE 3 14 60 6 274

Figure S202.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

'amp_22q12.2' versus 'Time to Death'

P value = 0.000495 (logrank test), Q value = 0.0019

Table S203.  Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 49(22Q12.2) MUTATED 61 17 0.4 - 191.8 (21.9)
AMP PEAK 49(22Q12.2) WILD-TYPE 465 52 0.1 - 185.8 (23.3)

Figure S203.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

'amp_22q12.2' versus 'YEARS_TO_BIRTH'

P value = 0.000572 (Wilcoxon-test), Q value = 0.0021

Table S204.  Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 49(22Q12.2) MUTATED 61 68.3 (10.1)
AMP PEAK 49(22Q12.2) WILD-TYPE 465 63.4 (11.2)

Figure S204.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_22q12.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S205.  Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 49(22Q12.2) MUTATED 11 2 49
AMP PEAK 49(22Q12.2) WILD-TYPE 384 19 63

Figure S205.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_22q12.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0474 (Fisher's exact test), Q value = 0.093

Table S206.  Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 49(22Q12.2) MUTATED 10 52
AMP PEAK 49(22Q12.2) WILD-TYPE 131 335

Figure S206.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_22q12.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00228 (Fisher's exact test), Q value = 0.0071

Table S207.  Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
AMP PEAK 49(22Q12.2) MUTATED 35 3 7 6
AMP PEAK 49(22Q12.2) WILD-TYPE 328 20 10 29

Figure S207.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_22q12.2' versus 'RACE'

P value = 0.0256 (Fisher's exact test), Q value = 0.055

Table S208.  Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
AMP PEAK 49(22Q12.2) MUTATED 0 1 21 0 34
AMP PEAK 49(22Q12.2) WILD-TYPE 4 19 80 9 332

Figure S208.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

'amp_xp11.23' versus 'Time to Death'

P value = 0.0887 (logrank test), Q value = 0.16

Table S209.  Gene #50: 'amp_xp11.23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 50(XP11.23) MUTATED 89 16 0.1 - 110.1 (22.6)
AMP PEAK 50(XP11.23) WILD-TYPE 437 53 0.2 - 191.8 (23.4)

Figure S209.  Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #1: 'Time to Death'

'amp_xp11.23' versus 'YEARS_TO_BIRTH'

P value = 0.029 (Wilcoxon-test), Q value = 0.061

Table S210.  Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 50(XP11.23) MUTATED 89 66.2 (11.2)
AMP PEAK 50(XP11.23) WILD-TYPE 437 63.6 (11.2)

Figure S210.  Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xp11.23' versus 'HISTOLOGICAL_TYPE'

P value = 0.00034 (Fisher's exact test), Q value = 0.0013

Table S211.  Gene #50: 'amp_xp11.23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 50(XP11.23) MUTATED 52 4 33
AMP PEAK 50(XP11.23) WILD-TYPE 343 17 79

Figure S211.  Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_xp11.23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.025 (Fisher's exact test), Q value = 0.054

Table S212.  Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
AMP PEAK 50(XP11.23) MUTATED 15 74
AMP PEAK 50(XP11.23) WILD-TYPE 126 313

Figure S212.  Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_xq28' versus 'Time to Death'

P value = 0.000466 (logrank test), Q value = 0.0018

Table S213.  Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
AMP PEAK 51(XQ28) MUTATED 88 21 0.1 - 110.1 (22.2)
AMP PEAK 51(XQ28) WILD-TYPE 438 48 0.1 - 191.8 (23.4)

Figure S213.  Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

'amp_xq28' versus 'YEARS_TO_BIRTH'

P value = 0.0513 (Wilcoxon-test), Q value = 0.099

Table S214.  Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
AMP PEAK 51(XQ28) MUTATED 88 66.1 (12.3)
AMP PEAK 51(XQ28) WILD-TYPE 438 63.6 (11.0)

Figure S214.  Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xq28' versus 'HISTOLOGICAL_TYPE'

P value = 0.00059 (Fisher's exact test), Q value = 0.0022

Table S215.  Gene #51: 'amp_xq28' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
AMP PEAK 51(XQ28) MUTATED 53 3 33
AMP PEAK 51(XQ28) WILD-TYPE 342 18 79

Figure S215.  Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.21' versus 'YEARS_TO_BIRTH'

P value = 0.000199 (Wilcoxon-test), Q value = 0.00086

Table S216.  Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 1(1P36.21) MUTATED 69 69.1 (10.2)
DEL PEAK 1(1P36.21) WILD-TYPE 457 63.2 (11.2)

Figure S216.  Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S217.  Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 1(1P36.21) MUTATED 26 5 38
DEL PEAK 1(1P36.21) WILD-TYPE 369 16 74

Figure S217.  Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'Time to Death'

P value = 0.00773 (logrank test), Q value = 0.02

Table S218.  Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 2(1P36.11) MUTATED 78 17 0.4 - 149.6 (20.5)
DEL PEAK 2(1P36.11) WILD-TYPE 448 52 0.1 - 191.8 (23.4)

Figure S218.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

'del_1p36.11' versus 'YEARS_TO_BIRTH'

P value = 9.85e-05 (Wilcoxon-test), Q value = 0.00047

Table S219.  Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 2(1P36.11) MUTATED 79 68.7 (9.4)
DEL PEAK 2(1P36.11) WILD-TYPE 447 63.2 (11.3)

Figure S219.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S220.  Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 2(1P36.11) MUTATED 25 5 49
DEL PEAK 2(1P36.11) WILD-TYPE 370 16 63

Figure S220.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0421 (Fisher's exact test), Q value = 0.085

Table S221.  Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 2(1P36.11) MUTATED 52 7 5 3
DEL PEAK 2(1P36.11) WILD-TYPE 311 16 12 32

Figure S221.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2p25.3' versus 'Time to Death'

P value = 0.0429 (logrank test), Q value = 0.086

Table S222.  Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 3(2P25.3) MUTATED 25 6 0.6 - 125.4 (18.9)
DEL PEAK 3(2P25.3) WILD-TYPE 501 63 0.1 - 191.8 (23.7)

Figure S222.  Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

'del_2p25.3' versus 'YEARS_TO_BIRTH'

P value = 0.071 (Wilcoxon-test), Q value = 0.13

Table S223.  Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 3(2P25.3) MUTATED 26 66.8 (7.9)
DEL PEAK 3(2P25.3) WILD-TYPE 500 63.9 (11.4)

Figure S223.  Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2p25.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.0104 (Fisher's exact test), Q value = 0.025

Table S224.  Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 3(2P25.3) MUTATED 13 2 11
DEL PEAK 3(2P25.3) WILD-TYPE 382 19 101

Figure S224.  Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2p25.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.109 (Fisher's exact test), Q value = 0.19

Table S225.  Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 3(2P25.3) MUTATED 3 23
DEL PEAK 3(2P25.3) WILD-TYPE 138 364

Figure S225.  Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q22.1' versus 'Time to Death'

P value = 1.26e-07 (logrank test), Q value = 5.2e-06

Table S226.  Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 4(2Q22.1) MUTATED 46 16 0.6 - 125.4 (16.9)
DEL PEAK 4(2Q22.1) WILD-TYPE 480 53 0.1 - 191.8 (23.9)

Figure S226.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

'del_2q22.1' versus 'YEARS_TO_BIRTH'

P value = 0.0048 (Wilcoxon-test), Q value = 0.013

Table S227.  Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 4(2Q22.1) MUTATED 46 68.0 (9.3)
DEL PEAK 4(2Q22.1) WILD-TYPE 480 63.6 (11.3)

Figure S227.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S228.  Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 4(2Q22.1) MUTATED 17 2 27
DEL PEAK 4(2Q22.1) WILD-TYPE 378 19 85

Figure S228.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2q22.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0027 (Fisher's exact test), Q value = 0.0081

Table S229.  Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 4(2Q22.1) MUTATED 4 42
DEL PEAK 4(2Q22.1) WILD-TYPE 137 345

Figure S229.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q22.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00162 (Fisher's exact test), Q value = 0.0052

Table S230.  Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 4(2Q22.1) MUTATED 24 2 5 7
DEL PEAK 4(2Q22.1) WILD-TYPE 339 21 12 28

Figure S230.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2q22.1' versus 'RACE'

P value = 0.0849 (Fisher's exact test), Q value = 0.15

Table S231.  Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 4(2Q22.1) MUTATED 0 1 16 1 26
DEL PEAK 4(2Q22.1) WILD-TYPE 4 19 85 8 340

Figure S231.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

'del_2q37.3' versus 'Time to Death'

P value = 0.0185 (logrank test), Q value = 0.041

Table S232.  Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 5(2Q37.3) MUTATED 51 12 0.6 - 102.3 (22.3)
DEL PEAK 5(2Q37.3) WILD-TYPE 475 57 0.1 - 191.8 (23.3)

Figure S232.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

'del_2q37.3' versus 'YEARS_TO_BIRTH'

P value = 0.00257 (Wilcoxon-test), Q value = 0.0079

Table S233.  Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 5(2Q37.3) MUTATED 52 68.2 (8.4)
DEL PEAK 5(2Q37.3) WILD-TYPE 474 63.5 (11.4)

Figure S233.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q37.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-04 (Fisher's exact test), Q value = 0.00047

Table S234.  Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 5(2Q37.3) MUTATED 26 2 24
DEL PEAK 5(2Q37.3) WILD-TYPE 369 19 88

Figure S234.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2q37.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.137 (Fisher's exact test), Q value = 0.22

Table S235.  Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 5(2Q37.3) MUTATED 9 43
DEL PEAK 5(2Q37.3) WILD-TYPE 132 344

Figure S235.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q37.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0439 (Fisher's exact test), Q value = 0.087

Table S236.  Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 5(2Q37.3) MUTATED 32 2 3 8
DEL PEAK 5(2Q37.3) WILD-TYPE 331 21 14 27

Figure S236.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2q37.3' versus 'RACE'

P value = 0.142 (Fisher's exact test), Q value = 0.23

Table S237.  Gene #56: 'del_2q37.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 5(2Q37.3) MUTATED 0 0 14 2 32
DEL PEAK 5(2Q37.3) WILD-TYPE 4 20 87 7 334

Figure S237.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #6: 'RACE'

'del_3p14.2' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S238.  Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 6(3P14.2) MUTATED 76 67.5 (8.0)
DEL PEAK 6(3P14.2) WILD-TYPE 450 63.4 (11.6)

Figure S238.  Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3p14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S239.  Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 6(3P14.2) MUTATED 27 6 44
DEL PEAK 6(3P14.2) WILD-TYPE 368 15 68

Figure S239.  Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_3p14.2' versus 'RACE'

P value = 0.022 (Fisher's exact test), Q value = 0.048

Table S240.  Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 6(3P14.2) MUTATED 0 1 25 0 47
DEL PEAK 6(3P14.2) WILD-TYPE 4 19 76 9 319

Figure S240.  Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

'del_3p14.2' versus 'ETHNICITY'

P value = 0.141 (Fisher's exact test), Q value = 0.23

Table S241.  Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
DEL PEAK 6(3P14.2) MUTATED 0 58
DEL PEAK 6(3P14.2) WILD-TYPE 14 309

Figure S241.  Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

'del_3q13.31' versus 'YEARS_TO_BIRTH'

P value = 0.000389 (Wilcoxon-test), Q value = 0.0015

Table S242.  Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 7(3Q13.31) MUTATED 42 69.4 (10.2)
DEL PEAK 7(3Q13.31) WILD-TYPE 484 63.5 (11.2)

Figure S242.  Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3q13.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S243.  Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 7(3Q13.31) MUTATED 17 3 22
DEL PEAK 7(3Q13.31) WILD-TYPE 378 18 90

Figure S243.  Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p16.3' versus 'Time to Death'

P value = 0.00202 (logrank test), Q value = 0.0063

Table S244.  Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 8(4P16.3) MUTATED 88 19 0.2 - 149.6 (20.0)
DEL PEAK 8(4P16.3) WILD-TYPE 438 50 0.1 - 191.8 (23.9)

Figure S244.  Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

'del_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 0.000181 (Wilcoxon-test), Q value = 8e-04

Table S245.  Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 8(4P16.3) MUTATED 89 68.0 (9.0)
DEL PEAK 8(4P16.3) WILD-TYPE 437 63.2 (11.5)

Figure S245.  Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S246.  Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 8(4P16.3) MUTATED 29 5 55
DEL PEAK 8(4P16.3) WILD-TYPE 366 16 57

Figure S246.  Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p15.2' versus 'Time to Death'

P value = 0.00057 (logrank test), Q value = 0.0021

Table S247.  Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 9(4P15.2) MUTATED 92 21 0.2 - 149.6 (20.0)
DEL PEAK 9(4P15.2) WILD-TYPE 434 48 0.1 - 191.8 (23.9)

Figure S247.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

'del_4p15.2' versus 'YEARS_TO_BIRTH'

P value = 7.19e-05 (Wilcoxon-test), Q value = 0.00036

Table S248.  Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 9(4P15.2) MUTATED 93 68.2 (9.1)
DEL PEAK 9(4P15.2) WILD-TYPE 433 63.1 (11.4)

Figure S248.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p15.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S249.  Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 9(4P15.2) MUTATED 31 5 57
DEL PEAK 9(4P15.2) WILD-TYPE 364 16 55

Figure S249.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p15.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0929 (Fisher's exact test), Q value = 0.16

Table S250.  Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 9(4P15.2) MUTATED 18 75
DEL PEAK 9(4P15.2) WILD-TYPE 123 312

Figure S250.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q22.1' versus 'Time to Death'

P value = 0.00539 (logrank test), Q value = 0.015

Table S251.  Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 10(4Q22.1) MUTATED 101 22 0.2 - 149.6 (21.2)
DEL PEAK 10(4Q22.1) WILD-TYPE 425 47 0.1 - 191.8 (23.5)

Figure S251.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

'del_4q22.1' versus 'YEARS_TO_BIRTH'

P value = 8e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S252.  Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 10(4Q22.1) MUTATED 102 68.3 (8.9)
DEL PEAK 10(4Q22.1) WILD-TYPE 424 63.0 (11.5)

Figure S252.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S253.  Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 10(4Q22.1) MUTATED 30 6 66
DEL PEAK 10(4Q22.1) WILD-TYPE 365 15 46

Figure S253.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4q22.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S254.  Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 10(4Q22.1) MUTATED 21 81
DEL PEAK 10(4Q22.1) WILD-TYPE 120 306

Figure S254.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q22.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0787 (Fisher's exact test), Q value = 0.14

Table S255.  Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 10(4Q22.1) MUTATED 63 6 7 7
DEL PEAK 10(4Q22.1) WILD-TYPE 300 17 10 28

Figure S255.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_4q34.3' versus 'Time to Death'

P value = 0.00667 (logrank test), Q value = 0.017

Table S256.  Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 11(4Q34.3) MUTATED 126 25 0.2 - 149.6 (20.8)
DEL PEAK 11(4Q34.3) WILD-TYPE 400 44 0.1 - 191.8 (23.7)

Figure S256.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

'del_4q34.3' versus 'YEARS_TO_BIRTH'

P value = 6.72e-07 (Wilcoxon-test), Q value = 2.4e-05

Table S257.  Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 11(4Q34.3) MUTATED 127 68.0 (9.8)
DEL PEAK 11(4Q34.3) WILD-TYPE 399 62.7 (11.4)

Figure S257.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S258.  Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 11(4Q34.3) MUTATED 43 8 76
DEL PEAK 11(4Q34.3) WILD-TYPE 352 13 36

Figure S258.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4q34.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.134 (Fisher's exact test), Q value = 0.22

Table S259.  Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 11(4Q34.3) MUTATED 27 100
DEL PEAK 11(4Q34.3) WILD-TYPE 114 287

Figure S259.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q34.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.137 (Fisher's exact test), Q value = 0.22

Table S260.  Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 11(4Q34.3) MUTATED 81 6 8 7
DEL PEAK 11(4Q34.3) WILD-TYPE 282 17 9 28

Figure S260.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_4q34.3' versus 'RACE'

P value = 0.0115 (Fisher's exact test), Q value = 0.028

Table S261.  Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 11(4Q34.3) MUTATED 0 4 37 3 75
DEL PEAK 11(4Q34.3) WILD-TYPE 4 16 64 6 291

Figure S261.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

'del_5q12.1' versus 'Time to Death'

P value = 0.00485 (logrank test), Q value = 0.013

Table S262.  Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 12(5Q12.1) MUTATED 108 23 0.2 - 149.6 (22.0)
DEL PEAK 12(5Q12.1) WILD-TYPE 418 46 0.1 - 191.8 (23.6)

Figure S262.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

'del_5q12.1' versus 'YEARS_TO_BIRTH'

P value = 6.11e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S263.  Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 12(5Q12.1) MUTATED 108 67.9 (9.7)
DEL PEAK 12(5Q12.1) WILD-TYPE 418 63.0 (11.4)

Figure S263.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_5q12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S264.  Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 12(5Q12.1) MUTATED 35 4 70
DEL PEAK 12(5Q12.1) WILD-TYPE 360 17 42

Figure S264.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_5q12.1' versus 'RACE'

P value = 0.0747 (Fisher's exact test), Q value = 0.14

Table S265.  Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 12(5Q12.1) MUTATED 0 3 29 3 64
DEL PEAK 12(5Q12.1) WILD-TYPE 4 17 72 6 302

Figure S265.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

'del_6q26' versus 'YEARS_TO_BIRTH'

P value = 0.00651 (Wilcoxon-test), Q value = 0.017

Table S266.  Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 13(6Q26) MUTATED 45 68.7 (11.1)
DEL PEAK 13(6Q26) WILD-TYPE 481 63.6 (11.1)

Figure S266.  Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_6q26' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S267.  Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 13(6Q26) MUTATED 13 3 29
DEL PEAK 13(6Q26) WILD-TYPE 382 18 83

Figure S267.  Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'Time to Death'

P value = 0.00112 (logrank test), Q value = 0.0039

Table S268.  Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 14(7P22.3) MUTATED 69 17 0.6 - 110.1 (23.2)
DEL PEAK 14(7P22.3) WILD-TYPE 457 52 0.1 - 191.8 (23.4)

Figure S268.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

'del_7p22.3' versus 'YEARS_TO_BIRTH'

P value = 6.52e-05 (Wilcoxon-test), Q value = 0.00034

Table S269.  Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 14(7P22.3) MUTATED 69 68.8 (10.1)
DEL PEAK 14(7P22.3) WILD-TYPE 457 63.3 (11.2)

Figure S269.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S270.  Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 14(7P22.3) MUTATED 21 5 44
DEL PEAK 14(7P22.3) WILD-TYPE 374 16 68

Figure S270.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'RACE'

P value = 0.119 (Fisher's exact test), Q value = 0.2

Table S271.  Gene #65: 'del_7p22.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 14(7P22.3) MUTATED 0 2 21 1 40
DEL PEAK 14(7P22.3) WILD-TYPE 4 18 80 8 326

Figure S271.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #6: 'RACE'

'del_7q11.22' versus 'YEARS_TO_BIRTH'

P value = 5.17e-05 (Wilcoxon-test), Q value = 0.00027

Table S272.  Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 15(7Q11.22) MUTATED 39 70.7 (9.8)
DEL PEAK 15(7Q11.22) WILD-TYPE 487 63.5 (11.2)

Figure S272.  Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q11.22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S273.  Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 15(7Q11.22) MUTATED 13 2 24
DEL PEAK 15(7Q11.22) WILD-TYPE 382 19 88

Figure S273.  Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7q31.1' versus 'Time to Death'

P value = 0.0267 (logrank test), Q value = 0.057

Table S274.  Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 16(7Q31.1) MUTATED 53 12 0.1 - 110.1 (22.1)
DEL PEAK 16(7Q31.1) WILD-TYPE 473 57 0.1 - 191.8 (23.5)

Figure S274.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

'del_7q31.1' versus 'YEARS_TO_BIRTH'

P value = 5.65e-05 (Wilcoxon-test), Q value = 3e-04

Table S275.  Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 16(7Q31.1) MUTATED 53 69.5 (7.8)
DEL PEAK 16(7Q31.1) WILD-TYPE 473 63.4 (11.4)

Figure S275.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q31.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S276.  Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 16(7Q31.1) MUTATED 10 3 40
DEL PEAK 16(7Q31.1) WILD-TYPE 385 18 72

Figure S276.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7q31.1' versus 'RACE'

P value = 0.114 (Fisher's exact test), Q value = 0.19

Table S277.  Gene #67: 'del_7q31.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 16(7Q31.1) MUTATED 0 0 16 1 31
DEL PEAK 16(7Q31.1) WILD-TYPE 4 20 85 8 335

Figure S277.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #6: 'RACE'

'del_7q36.1' versus 'Time to Death'

P value = 0.00848 (logrank test), Q value = 0.021

Table S278.  Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 17(7Q36.1) MUTATED 62 15 1.2 - 125.4 (22.2)
DEL PEAK 17(7Q36.1) WILD-TYPE 464 54 0.1 - 191.8 (23.5)

Figure S278.  Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

'del_7q36.1' versus 'YEARS_TO_BIRTH'

P value = 3.24e-07 (Wilcoxon-test), Q value = 1.3e-05

Table S279.  Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 17(7Q36.1) MUTATED 62 70.6 (8.5)
DEL PEAK 17(7Q36.1) WILD-TYPE 464 63.1 (11.3)

Figure S279.  Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q36.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S280.  Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 17(7Q36.1) MUTATED 12 4 46
DEL PEAK 17(7Q36.1) WILD-TYPE 383 17 66

Figure S280.  Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'Time to Death'

P value = 0.000772 (logrank test), Q value = 0.0028

Table S281.  Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 18(8P23.2) MUTATED 113 26 0.3 - 191.8 (22.3)
DEL PEAK 18(8P23.2) WILD-TYPE 413 43 0.1 - 185.8 (23.5)

Figure S281.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

'del_8p23.2' versus 'YEARS_TO_BIRTH'

P value = 2.17e-05 (Wilcoxon-test), Q value = 0.00012

Table S282.  Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 18(8P23.2) MUTATED 113 67.6 (9.2)
DEL PEAK 18(8P23.2) WILD-TYPE 413 63.0 (11.5)

Figure S282.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p23.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S283.  Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 18(8P23.2) MUTATED 34 5 76
DEL PEAK 18(8P23.2) WILD-TYPE 361 16 36

Figure S283.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.122 (Fisher's exact test), Q value = 0.2

Table S284.  Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 18(8P23.2) MUTATED 24 91
DEL PEAK 18(8P23.2) WILD-TYPE 117 296

Figure S284.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_8p23.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0585 (Fisher's exact test), Q value = 0.11

Table S285.  Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 18(8P23.2) MUTATED 69 5 7 11
DEL PEAK 18(8P23.2) WILD-TYPE 294 18 10 24

Figure S285.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_8p23.2' versus 'RACE'

P value = 0.00564 (Fisher's exact test), Q value = 0.015

Table S286.  Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 18(8P23.2) MUTATED 1 2 35 2 67
DEL PEAK 18(8P23.2) WILD-TYPE 3 18 66 7 299

Figure S286.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

'del_8p21.2' versus 'Time to Death'

P value = 0.00679 (logrank test), Q value = 0.017

Table S287.  Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 19(8P21.2) MUTATED 112 24 0.3 - 191.8 (23.5)
DEL PEAK 19(8P21.2) WILD-TYPE 414 45 0.1 - 185.8 (23.3)

Figure S287.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

'del_8p21.2' versus 'YEARS_TO_BIRTH'

P value = 2.6e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S288.  Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 19(8P21.2) MUTATED 112 68.1 (9.1)
DEL PEAK 19(8P21.2) WILD-TYPE 414 62.9 (11.5)

Figure S288.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S289.  Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 19(8P21.2) MUTATED 26 6 81
DEL PEAK 19(8P21.2) WILD-TYPE 369 15 31

Figure S289.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.151 (Fisher's exact test), Q value = 0.24

Table S290.  Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 19(8P21.2) MUTATED 24 89
DEL PEAK 19(8P21.2) WILD-TYPE 117 298

Figure S290.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_8p21.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.146 (Fisher's exact test), Q value = 0.23

Table S291.  Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 19(8P21.2) MUTATED 70 5 7 9
DEL PEAK 19(8P21.2) WILD-TYPE 293 18 10 26

Figure S291.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_8p21.2' versus 'RACE'

P value = 0.00731 (Fisher's exact test), Q value = 0.019

Table S292.  Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 19(8P21.2) MUTATED 1 2 34 2 65
DEL PEAK 19(8P21.2) WILD-TYPE 3 18 67 7 301

Figure S292.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

'del_9p23' versus 'Time to Death'

P value = 0.0163 (logrank test), Q value = 0.037

Table S293.  Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 20(9P23) MUTATED 76 17 0.3 - 149.6 (21.4)
DEL PEAK 20(9P23) WILD-TYPE 450 52 0.1 - 191.8 (23.5)

Figure S293.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

'del_9p23' versus 'YEARS_TO_BIRTH'

P value = 0.00143 (Wilcoxon-test), Q value = 0.0047

Table S294.  Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 20(9P23) MUTATED 76 67.7 (9.2)
DEL PEAK 20(9P23) WILD-TYPE 450 63.4 (11.4)

Figure S294.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9p23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S295.  Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 20(9P23) MUTATED 28 4 44
DEL PEAK 20(9P23) WILD-TYPE 367 17 68

Figure S295.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9p23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0491 (Fisher's exact test), Q value = 0.096

Table S296.  Gene #71: 'del_9p23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 20(9P23) MUTATED 13 63
DEL PEAK 20(9P23) WILD-TYPE 128 324

Figure S296.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_9p23' versus 'RACE'

P value = 0.13 (Fisher's exact test), Q value = 0.21

Table S297.  Gene #71: 'del_9p23' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 20(9P23) MUTATED 1 2 21 2 45
DEL PEAK 20(9P23) WILD-TYPE 3 18 80 7 321

Figure S297.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #6: 'RACE'

'del_9q21.2' versus 'Time to Death'

P value = 1.41e-05 (logrank test), Q value = 8.1e-05

Table S298.  Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 21(9Q21.2) MUTATED 126 31 0.1 - 125.4 (21.9)
DEL PEAK 21(9Q21.2) WILD-TYPE 400 38 0.1 - 191.8 (23.7)

Figure S298.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

'del_9q21.2' versus 'YEARS_TO_BIRTH'

P value = 5.38e-10 (Wilcoxon-test), Q value = 9.4e-08

Table S299.  Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 21(9Q21.2) MUTATED 125 69.2 (8.9)
DEL PEAK 21(9Q21.2) WILD-TYPE 401 62.4 (11.4)

Figure S299.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S300.  Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 21(9Q21.2) MUTATED 49 10 67
DEL PEAK 21(9Q21.2) WILD-TYPE 346 11 45

Figure S300.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9q21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S301.  Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 21(9Q21.2) MUTATED 27 99
DEL PEAK 21(9Q21.2) WILD-TYPE 114 288

Figure S301.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_9q21.2' versus 'RACE'

P value = 0.0288 (Fisher's exact test), Q value = 0.061

Table S302.  Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 21(9Q21.2) MUTATED 1 1 34 2 81
DEL PEAK 21(9Q21.2) WILD-TYPE 3 19 67 7 285

Figure S302.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

'del_9q34.2' versus 'Time to Death'

P value = 0.000133 (logrank test), Q value = 0.00061

Table S303.  Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 22(9Q34.2) MUTATED 127 30 0.2 - 125.4 (23.7)
DEL PEAK 22(9Q34.2) WILD-TYPE 399 39 0.1 - 191.8 (23.3)

Figure S303.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

'del_9q34.2' versus 'YEARS_TO_BIRTH'

P value = 2.65e-08 (Wilcoxon-test), Q value = 1.4e-06

Table S304.  Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 22(9Q34.2) MUTATED 127 68.6 (8.5)
DEL PEAK 22(9Q34.2) WILD-TYPE 399 62.5 (11.6)

Figure S304.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S305.  Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 22(9Q34.2) MUTATED 52 10 66
DEL PEAK 22(9Q34.2) WILD-TYPE 343 11 46

Figure S305.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9q34.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.109 (Fisher's exact test), Q value = 0.19

Table S306.  Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 22(9Q34.2) MUTATED 27 101
DEL PEAK 22(9Q34.2) WILD-TYPE 114 286

Figure S306.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_10q23.31' versus 'Time to Death'

P value = 0.00423 (logrank test), Q value = 0.012

Table S307.  Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 23(10Q23.31) MUTATED 74 16 0.3 - 125.4 (18.8)
DEL PEAK 23(10Q23.31) WILD-TYPE 452 53 0.1 - 191.8 (23.7)

Figure S307.  Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

'del_10q23.31' versus 'YEARS_TO_BIRTH'

P value = 0.000879 (Wilcoxon-test), Q value = 0.0032

Table S308.  Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 23(10Q23.31) MUTATED 74 67.7 (9.7)
DEL PEAK 23(10Q23.31) WILD-TYPE 452 63.4 (11.3)

Figure S308.  Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_10q23.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S309.  Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 23(10Q23.31) MUTATED 31 5 39
DEL PEAK 23(10Q23.31) WILD-TYPE 364 16 73

Figure S309.  Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_10q23.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00452 (Fisher's exact test), Q value = 0.013

Table S310.  Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 23(10Q23.31) MUTATED 10 65
DEL PEAK 23(10Q23.31) WILD-TYPE 131 322

Figure S310.  Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11p15.5' versus 'Time to Death'

P value = 0.0163 (logrank test), Q value = 0.037

Table S311.  Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 24(11P15.5) MUTATED 101 20 0.1 - 149.6 (20.5)
DEL PEAK 24(11P15.5) WILD-TYPE 425 49 0.1 - 191.8 (23.7)

Figure S311.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

'del_11p15.5' versus 'YEARS_TO_BIRTH'

P value = 1.22e-05 (Wilcoxon-test), Q value = 7e-05

Table S312.  Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 24(11P15.5) MUTATED 101 68.2 (8.9)
DEL PEAK 24(11P15.5) WILD-TYPE 425 63.0 (11.5)

Figure S312.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11p15.5' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S313.  Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 24(11P15.5) MUTATED 36 5 61
DEL PEAK 24(11P15.5) WILD-TYPE 359 16 51

Figure S313.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11p15.5' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00584 (Fisher's exact test), Q value = 0.015

Table S314.  Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 24(11P15.5) MUTATED 16 86
DEL PEAK 24(11P15.5) WILD-TYPE 125 301

Figure S314.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11p15.5' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0897 (Fisher's exact test), Q value = 0.16

Table S315.  Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 24(11P15.5) MUTATED 63 3 7 8
DEL PEAK 24(11P15.5) WILD-TYPE 300 20 10 27

Figure S315.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_11p15.5' versus 'RACE'

P value = 0.0548 (Fisher's exact test), Q value = 0.11

Table S316.  Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 24(11P15.5) MUTATED 1 3 30 1 62
DEL PEAK 24(11P15.5) WILD-TYPE 3 17 71 8 304

Figure S316.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'Time to Death'

P value = 0.0903 (logrank test), Q value = 0.16

Table S317.  Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 25(11Q14.1) MUTATED 70 12 0.3 - 116.2 (19.6)
DEL PEAK 25(11Q14.1) WILD-TYPE 456 57 0.1 - 191.8 (23.8)

Figure S317.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

'del_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.000288 (Wilcoxon-test), Q value = 0.0012

Table S318.  Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 25(11Q14.1) MUTATED 70 68.6 (8.8)
DEL PEAK 25(11Q14.1) WILD-TYPE 456 63.3 (11.4)

Figure S318.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S319.  Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 25(11Q14.1) MUTATED 21 6 43
DEL PEAK 25(11Q14.1) WILD-TYPE 374 15 69

Figure S319.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11q14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0591 (Fisher's exact test), Q value = 0.11

Table S320.  Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 25(11Q14.1) MUTATED 12 58
DEL PEAK 25(11Q14.1) WILD-TYPE 129 329

Figure S320.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11q14.1' versus 'RACE'

P value = 0.0717 (Fisher's exact test), Q value = 0.13

Table S321.  Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 25(11Q14.1) MUTATED 1 2 21 0 41
DEL PEAK 25(11Q14.1) WILD-TYPE 3 18 80 9 325

Figure S321.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'ETHNICITY'

P value = 0.0431 (Fisher's exact test), Q value = 0.086

Table S322.  Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
DEL PEAK 25(11Q14.1) MUTATED 5 52
DEL PEAK 25(11Q14.1) WILD-TYPE 9 315

Figure S322.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

'del_11q25' versus 'Time to Death'

P value = 0.00906 (logrank test), Q value = 0.022

Table S323.  Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 26(11Q25) MUTATED 92 18 0.3 - 116.2 (19.1)
DEL PEAK 26(11Q25) WILD-TYPE 434 51 0.1 - 191.8 (23.9)

Figure S323.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

'del_11q25' versus 'YEARS_TO_BIRTH'

P value = 0.000253 (Wilcoxon-test), Q value = 0.001

Table S324.  Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 26(11Q25) MUTATED 92 67.6 (9.7)
DEL PEAK 26(11Q25) WILD-TYPE 434 63.3 (11.4)

Figure S324.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q25' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S325.  Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 26(11Q25) MUTATED 32 6 54
DEL PEAK 26(11Q25) WILD-TYPE 363 15 58

Figure S325.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11q25' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00266 (Fisher's exact test), Q value = 0.0081

Table S326.  Gene #77: 'del_11q25' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 26(11Q25) MUTATED 13 79
DEL PEAK 26(11Q25) WILD-TYPE 128 308

Figure S326.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11q25' versus 'RACE'

P value = 0.0842 (Fisher's exact test), Q value = 0.15

Table S327.  Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 26(11Q25) MUTATED 1 2 26 1 54
DEL PEAK 26(11Q25) WILD-TYPE 3 18 75 8 312

Figure S327.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

'del_12q23.1' versus 'Time to Death'

P value = 0.000179 (logrank test), Q value = 8e-04

Table S328.  Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 27(12Q23.1) MUTATED 53 15 0.6 - 110.1 (21.9)
DEL PEAK 27(12Q23.1) WILD-TYPE 473 54 0.1 - 191.8 (23.5)

Figure S328.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

'del_12q23.1' versus 'YEARS_TO_BIRTH'

P value = 0.00236 (Wilcoxon-test), Q value = 0.0073

Table S329.  Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 27(12Q23.1) MUTATED 53 68.2 (9.5)
DEL PEAK 27(12Q23.1) WILD-TYPE 473 63.5 (11.3)

Figure S329.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S330.  Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 27(12Q23.1) MUTATED 12 3 38
DEL PEAK 27(12Q23.1) WILD-TYPE 383 18 74

Figure S330.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_12q23.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0491 (Fisher's exact test), Q value = 0.096

Table S331.  Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 27(12Q23.1) MUTATED 8 45
DEL PEAK 27(12Q23.1) WILD-TYPE 133 342

Figure S331.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_12q23.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.041 (Fisher's exact test), Q value = 0.083

Table S332.  Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 27(12Q23.1) MUTATED 33 1 4 7
DEL PEAK 27(12Q23.1) WILD-TYPE 330 22 13 28

Figure S332.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_12q23.1' versus 'RACE'

P value = 0.0413 (Fisher's exact test), Q value = 0.083

Table S333.  Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 27(12Q23.1) MUTATED 1 0 16 0 29
DEL PEAK 27(12Q23.1) WILD-TYPE 3 20 85 9 337

Figure S333.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

'del_12q24.33' versus 'Time to Death'

P value = 0.00562 (logrank test), Q value = 0.015

Table S334.  Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 28(12Q24.33) MUTATED 63 14 0.1 - 110.1 (20.8)
DEL PEAK 28(12Q24.33) WILD-TYPE 463 55 0.1 - 191.8 (23.6)

Figure S334.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

'del_12q24.33' versus 'YEARS_TO_BIRTH'

P value = 2.22e-05 (Wilcoxon-test), Q value = 0.00012

Table S335.  Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 28(12Q24.33) MUTATED 63 69.3 (8.7)
DEL PEAK 28(12Q24.33) WILD-TYPE 463 63.3 (11.3)

Figure S335.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q24.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S336.  Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 28(12Q24.33) MUTATED 18 2 43
DEL PEAK 28(12Q24.33) WILD-TYPE 377 19 69

Figure S336.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_12q24.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0219 (Fisher's exact test), Q value = 0.048

Table S337.  Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 28(12Q24.33) MUTATED 9 54
DEL PEAK 28(12Q24.33) WILD-TYPE 132 333

Figure S337.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_12q24.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0267 (Fisher's exact test), Q value = 0.057

Table S338.  Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 28(12Q24.33) MUTATED 39 2 5 8
DEL PEAK 28(12Q24.33) WILD-TYPE 324 21 12 27

Figure S338.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_13q11' versus 'Time to Death'

P value = 0.00311 (logrank test), Q value = 0.0093

Table S339.  Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 29(13Q11) MUTATED 93 22 0.1 - 149.6 (20.5)
DEL PEAK 29(13Q11) WILD-TYPE 433 47 0.1 - 191.8 (23.7)

Figure S339.  Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

'del_13q11' versus 'YEARS_TO_BIRTH'

P value = 0.00111 (Wilcoxon-test), Q value = 0.0039

Table S340.  Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 29(13Q11) MUTATED 93 67.2 (9.7)
DEL PEAK 29(13Q11) WILD-TYPE 433 63.3 (11.4)

Figure S340.  Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S341.  Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 29(13Q11) MUTATED 39 5 50
DEL PEAK 29(13Q11) WILD-TYPE 356 16 62

Figure S341.  Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_13q11' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0397 (Fisher's exact test), Q value = 0.081

Table S342.  Gene #80: 'del_13q11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 29(13Q11) MUTATED 17 77
DEL PEAK 29(13Q11) WILD-TYPE 124 310

Figure S342.  Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_13q14.2' versus 'Time to Death'

P value = 0.00126 (logrank test), Q value = 0.0042

Table S343.  Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 30(13Q14.2) MUTATED 102 22 0.1 - 149.6 (20.3)
DEL PEAK 30(13Q14.2) WILD-TYPE 424 47 0.1 - 191.8 (23.9)

Figure S343.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

'del_13q14.2' versus 'YEARS_TO_BIRTH'

P value = 0.00137 (Wilcoxon-test), Q value = 0.0045

Table S344.  Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 30(13Q14.2) MUTATED 102 67.1 (9.5)
DEL PEAK 30(13Q14.2) WILD-TYPE 424 63.3 (11.5)

Figure S344.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S345.  Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 30(13Q14.2) MUTATED 51 6 46
DEL PEAK 30(13Q14.2) WILD-TYPE 344 15 66

Figure S345.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_13q14.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.009 (Fisher's exact test), Q value = 0.022

Table S346.  Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 30(13Q14.2) MUTATED 17 86
DEL PEAK 30(13Q14.2) WILD-TYPE 124 301

Figure S346.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_13q14.2' versus 'RACE'

P value = 0.154 (Fisher's exact test), Q value = 0.24

Table S347.  Gene #81: 'del_13q14.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 30(13Q14.2) MUTATED 0 2 28 2 66
DEL PEAK 30(13Q14.2) WILD-TYPE 4 18 73 7 300

Figure S347.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #6: 'RACE'

'del_14q13.1' versus 'Time to Death'

P value = 0.00804 (logrank test), Q value = 0.02

Table S348.  Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 31(14Q13.1) MUTATED 71 14 0.1 - 125.4 (17.9)
DEL PEAK 31(14Q13.1) WILD-TYPE 455 55 0.1 - 191.8 (23.9)

Figure S348.  Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

'del_14q13.1' versus 'YEARS_TO_BIRTH'

P value = 0.00402 (Wilcoxon-test), Q value = 0.012

Table S349.  Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 31(14Q13.1) MUTATED 71 67.2 (9.9)
DEL PEAK 31(14Q13.1) WILD-TYPE 455 63.5 (11.3)

Figure S349.  Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_14q13.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S350.  Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 31(14Q13.1) MUTATED 25 5 41
DEL PEAK 31(14Q13.1) WILD-TYPE 370 16 71

Figure S350.  Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_14q13.1' versus 'RACE'

P value = 0.00394 (Fisher's exact test), Q value = 0.011

Table S351.  Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 31(14Q13.1) MUTATED 1 1 25 1 38
DEL PEAK 31(14Q13.1) WILD-TYPE 3 19 76 8 328

Figure S351.  Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

'del_15q15.1' versus 'Time to Death'

P value = 7.04e-05 (logrank test), Q value = 0.00036

Table S352.  Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 32(15Q15.1) MUTATED 135 30 0.1 - 116.2 (20.8)
DEL PEAK 32(15Q15.1) WILD-TYPE 391 39 0.1 - 191.8 (23.9)

Figure S352.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

'del_15q15.1' versus 'YEARS_TO_BIRTH'

P value = 2.37e-08 (Wilcoxon-test), Q value = 1.4e-06

Table S353.  Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 32(15Q15.1) MUTATED 136 68.4 (9.6)
DEL PEAK 32(15Q15.1) WILD-TYPE 390 62.5 (11.4)

Figure S353.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q15.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S354.  Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 32(15Q15.1) MUTATED 52 9 75
DEL PEAK 32(15Q15.1) WILD-TYPE 343 12 37

Figure S354.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_15q15.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0131 (Fisher's exact test), Q value = 0.031

Table S355.  Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 32(15Q15.1) MUTATED 25 111
DEL PEAK 32(15Q15.1) WILD-TYPE 116 276

Figure S355.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_15q15.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0396 (Fisher's exact test), Q value = 0.081

Table S356.  Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 32(15Q15.1) MUTATED 83 7 8 13
DEL PEAK 32(15Q15.1) WILD-TYPE 280 16 9 22

Figure S356.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_15q15.1' versus 'RACE'

P value = 0.0549 (Fisher's exact test), Q value = 0.11

Table S357.  Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 32(15Q15.1) MUTATED 1 2 35 3 84
DEL PEAK 32(15Q15.1) WILD-TYPE 3 18 66 6 282

Figure S357.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

'del_15q23' versus 'Time to Death'

P value = 0.0119 (logrank test), Q value = 0.029

Table S358.  Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 33(15Q23) MUTATED 113 21 0.2 - 125.4 (19.4)
DEL PEAK 33(15Q23) WILD-TYPE 413 48 0.1 - 191.8 (24.6)

Figure S358.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

'del_15q23' versus 'YEARS_TO_BIRTH'

P value = 8.57e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S359.  Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 33(15Q23) MUTATED 113 67.8 (9.4)
DEL PEAK 33(15Q23) WILD-TYPE 413 63.0 (11.5)

Figure S359.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S360.  Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 33(15Q23) MUTATED 38 7 68
DEL PEAK 33(15Q23) WILD-TYPE 357 14 44

Figure S360.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_15q23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0551 (Fisher's exact test), Q value = 0.11

Table S361.  Gene #84: 'del_15q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 33(15Q23) MUTATED 22 91
DEL PEAK 33(15Q23) WILD-TYPE 119 296

Figure S361.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_15q23' versus 'RACE'

P value = 0.0338 (Fisher's exact test), Q value = 0.069

Table S362.  Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 33(15Q23) MUTATED 0 2 32 1 68
DEL PEAK 33(15Q23) WILD-TYPE 4 18 69 8 298

Figure S362.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

'del_16p13.3' versus 'Time to Death'

P value = 0.00536 (logrank test), Q value = 0.014

Table S363.  Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 34(16P13.3) MUTATED 89 19 0.1 - 125.4 (21.9)
DEL PEAK 34(16P13.3) WILD-TYPE 437 50 0.1 - 191.8 (23.5)

Figure S363.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

'del_16p13.3' versus 'YEARS_TO_BIRTH'

P value = 2.2e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S364.  Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 34(16P13.3) MUTATED 90 68.9 (8.6)
DEL PEAK 34(16P13.3) WILD-TYPE 436 63.0 (11.4)

Figure S364.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S365.  Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 34(16P13.3) MUTATED 26 5 59
DEL PEAK 34(16P13.3) WILD-TYPE 369 16 53

Figure S365.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0682 (Fisher's exact test), Q value = 0.13

Table S366.  Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 34(16P13.3) MUTATED 17 73
DEL PEAK 34(16P13.3) WILD-TYPE 124 314

Figure S366.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_16p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.105 (Fisher's exact test), Q value = 0.18

Table S367.  Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 34(16P13.3) MUTATED 53 6 5 8
DEL PEAK 34(16P13.3) WILD-TYPE 310 17 12 27

Figure S367.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_16p13.3' versus 'RACE'

P value = 0.0297 (Fisher's exact test), Q value = 0.062

Table S368.  Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 34(16P13.3) MUTATED 0 2 28 1 53
DEL PEAK 34(16P13.3) WILD-TYPE 4 18 73 8 313

Figure S368.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

'del_16q21' versus 'Time to Death'

P value = 0.00957 (logrank test), Q value = 0.024

Table S369.  Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 35(16Q21) MUTATED 149 27 0.1 - 113.4 (22.0)
DEL PEAK 35(16Q21) WILD-TYPE 377 42 0.1 - 191.8 (23.6)

Figure S369.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

'del_16q21' versus 'YEARS_TO_BIRTH'

P value = 1.31e-08 (Wilcoxon-test), Q value = 1e-06

Table S370.  Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 35(16Q21) MUTATED 150 68.1 (9.1)
DEL PEAK 35(16Q21) WILD-TYPE 376 62.4 (11.6)

Figure S370.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S371.  Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 35(16Q21) MUTATED 63 8 79
DEL PEAK 35(16Q21) WILD-TYPE 332 13 33

Figure S371.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.082 (Fisher's exact test), Q value = 0.15

Table S372.  Gene #86: 'del_16q21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 35(16Q21) MUTATED 32 118
DEL PEAK 35(16Q21) WILD-TYPE 109 269

Figure S372.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_16q21' versus 'RACE'

P value = 0.0232 (Fisher's exact test), Q value = 0.051

Table S373.  Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 35(16Q21) MUTATED 1 2 40 2 95
DEL PEAK 35(16Q21) WILD-TYPE 3 18 61 7 271

Figure S373.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

'del_16q22.3' versus 'Time to Death'

P value = 0.0289 (logrank test), Q value = 0.061

Table S374.  Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 36(16Q22.3) MUTATED 153 26 0.1 - 113.4 (20.8)
DEL PEAK 36(16Q22.3) WILD-TYPE 373 43 0.1 - 191.8 (23.9)

Figure S374.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

'del_16q22.3' versus 'YEARS_TO_BIRTH'

P value = 5.81e-09 (Wilcoxon-test), Q value = 6.8e-07

Table S375.  Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 36(16Q22.3) MUTATED 154 68.0 (8.9)
DEL PEAK 36(16Q22.3) WILD-TYPE 372 62.3 (11.6)

Figure S375.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S376.  Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 36(16Q22.3) MUTATED 67 8 79
DEL PEAK 36(16Q22.3) WILD-TYPE 328 13 33

Figure S376.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q22.3' versus 'RACE'

P value = 0.0323 (Fisher's exact test), Q value = 0.066

Table S377.  Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 36(16Q22.3) MUTATED 1 2 40 2 98
DEL PEAK 36(16Q22.3) WILD-TYPE 3 18 61 7 268

Figure S377.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

'del_16q23.1' versus 'Time to Death'

P value = 0.00282 (logrank test), Q value = 0.0085

Table S378.  Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 37(16Q23.1) MUTATED 161 30 0.1 - 113.4 (21.2)
DEL PEAK 37(16Q23.1) WILD-TYPE 365 39 0.1 - 191.8 (23.9)

Figure S378.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

'del_16q23.1' versus 'YEARS_TO_BIRTH'

P value = 8.79e-09 (Wilcoxon-test), Q value = 8.8e-07

Table S379.  Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 37(16Q23.1) MUTATED 162 67.8 (9.3)
DEL PEAK 37(16Q23.1) WILD-TYPE 364 62.3 (11.6)

Figure S379.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S380.  Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 37(16Q23.1) MUTATED 69 7 86
DEL PEAK 37(16Q23.1) WILD-TYPE 326 14 26

Figure S380.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q23.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0173 (Fisher's exact test), Q value = 0.039

Table S381.  Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 37(16Q23.1) MUTATED 102 8 11 12
DEL PEAK 37(16Q23.1) WILD-TYPE 261 15 6 23

Figure S381.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_16q23.1' versus 'RACE'

P value = 0.00318 (Fisher's exact test), Q value = 0.0094

Table S382.  Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 37(16Q23.1) MUTATED 1 3 46 2 99
DEL PEAK 37(16Q23.1) WILD-TYPE 3 17 55 7 267

Figure S382.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

'del_17p13.3' versus 'Time to Death'

P value = 0.000112 (logrank test), Q value = 0.00052

Table S383.  Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 38(17P13.3) MUTATED 118 27 0.1 - 125.4 (20.6)
DEL PEAK 38(17P13.3) WILD-TYPE 408 42 0.1 - 191.8 (23.9)

Figure S383.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

'del_17p13.3' versus 'YEARS_TO_BIRTH'

P value = 0.000232 (Wilcoxon-test), Q value = 0.00097

Table S384.  Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 38(17P13.3) MUTATED 118 67.0 (9.0)
DEL PEAK 38(17P13.3) WILD-TYPE 408 63.1 (11.6)

Figure S384.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S385.  Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 38(17P13.3) MUTATED 46 9 64
DEL PEAK 38(17P13.3) WILD-TYPE 349 12 48

Figure S385.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0451 (Fisher's exact test), Q value = 0.089

Table S386.  Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 38(17P13.3) MUTATED 23 96
DEL PEAK 38(17P13.3) WILD-TYPE 118 291

Figure S386.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.146 (Fisher's exact test), Q value = 0.23

Table S387.  Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 38(17P13.3) MUTATED 72 7 4 12
DEL PEAK 38(17P13.3) WILD-TYPE 291 16 13 23

Figure S387.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_17p13.3' versus 'RACE'

P value = 0.00155 (Fisher's exact test), Q value = 0.0051

Table S388.  Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 38(17P13.3) MUTATED 0 2 37 3 69
DEL PEAK 38(17P13.3) WILD-TYPE 4 18 64 6 297

Figure S388.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

'del_17p11.2' versus 'Time to Death'

P value = 0.000381 (logrank test), Q value = 0.0015

Table S389.  Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 39(17P11.2) MUTATED 123 27 0.1 - 125.4 (20.5)
DEL PEAK 39(17P11.2) WILD-TYPE 403 42 0.1 - 191.8 (23.9)

Figure S389.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

'del_17p11.2' versus 'YEARS_TO_BIRTH'

P value = 4.49e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S390.  Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 39(17P11.2) MUTATED 123 67.7 (9.3)
DEL PEAK 39(17P11.2) WILD-TYPE 403 62.9 (11.5)

Figure S390.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S391.  Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 39(17P11.2) MUTATED 45 8 71
DEL PEAK 39(17P11.2) WILD-TYPE 350 13 41

Figure S391.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17p11.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.105 (Fisher's exact test), Q value = 0.18

Table S392.  Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 39(17P11.2) MUTATED 26 98
DEL PEAK 39(17P11.2) WILD-TYPE 115 289

Figure S392.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17p11.2' versus 'RACE'

P value = 0.0125 (Fisher's exact test), Q value = 0.03

Table S393.  Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 39(17P11.2) MUTATED 0 2 36 1 77
DEL PEAK 39(17P11.2) WILD-TYPE 4 18 65 8 289

Figure S393.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

'del_17q11.2' versus 'Time to Death'

P value = 0.0291 (logrank test), Q value = 0.061

Table S394.  Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 40(17Q11.2) MUTATED 100 20 0.2 - 125.4 (22.3)
DEL PEAK 40(17Q11.2) WILD-TYPE 426 49 0.1 - 191.8 (23.4)

Figure S394.  Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

'del_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 8.58e-07 (Wilcoxon-test), Q value = 2.7e-05

Table S395.  Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 40(17Q11.2) MUTATED 101 68.3 (9.4)
DEL PEAK 40(17Q11.2) WILD-TYPE 425 63.0 (11.4)

Figure S395.  Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S396.  Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 40(17Q11.2) MUTATED 43 5 53
DEL PEAK 40(17Q11.2) WILD-TYPE 352 16 59

Figure S396.  Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'Time to Death'

P value = 0.000198 (logrank test), Q value = 0.00086

Table S397.  Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 41(17Q21.31) MUTATED 108 26 0.2 - 125.4 (22.3)
DEL PEAK 41(17Q21.31) WILD-TYPE 418 43 0.1 - 191.8 (23.4)

Figure S397.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

'del_17q21.31' versus 'YEARS_TO_BIRTH'

P value = 1.18e-05 (Wilcoxon-test), Q value = 6.9e-05

Table S398.  Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 41(17Q21.31) MUTATED 108 67.9 (9.7)
DEL PEAK 41(17Q21.31) WILD-TYPE 418 63.0 (11.4)

Figure S398.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q21.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S399.  Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 41(17Q21.31) MUTATED 44 5 60
DEL PEAK 41(17Q21.31) WILD-TYPE 351 16 52

Figure S399.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0522 (Fisher's exact test), Q value = 0.1

Table S400.  Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 41(17Q21.31) MUTATED 21 88
DEL PEAK 41(17Q21.31) WILD-TYPE 120 299

Figure S400.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17q21.31' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0707 (Fisher's exact test), Q value = 0.13

Table S401.  Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 41(17Q21.31) MUTATED 66 6 6 11
DEL PEAK 41(17Q21.31) WILD-TYPE 297 17 11 24

Figure S401.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_17q21.31' versus 'ETHNICITY'

P value = 0.0481 (Fisher's exact test), Q value = 0.094

Table S402.  Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
DEL PEAK 41(17Q21.31) MUTATED 6 73
DEL PEAK 41(17Q21.31) WILD-TYPE 8 294

Figure S402.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

'del_18q21.2' versus 'YEARS_TO_BIRTH'

P value = 3e-04 (Wilcoxon-test), Q value = 0.0012

Table S403.  Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 42(18Q21.2) MUTATED 89 67.6 (9.8)
DEL PEAK 42(18Q21.2) WILD-TYPE 437 63.3 (11.4)

Figure S403.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S404.  Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 42(18Q21.2) MUTATED 37 6 46
DEL PEAK 42(18Q21.2) WILD-TYPE 358 15 66

Figure S404.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_18q21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00383 (Fisher's exact test), Q value = 0.011

Table S405.  Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 42(18Q21.2) MUTATED 13 76
DEL PEAK 42(18Q21.2) WILD-TYPE 128 311

Figure S405.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_18q21.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.129 (Fisher's exact test), Q value = 0.21

Table S406.  Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 42(18Q21.2) MUTATED 51 5 5 8
DEL PEAK 42(18Q21.2) WILD-TYPE 312 18 12 27

Figure S406.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_18q21.2' versus 'RACE'

P value = 0.0696 (Fisher's exact test), Q value = 0.13

Table S407.  Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 42(18Q21.2) MUTATED 0 2 25 3 54
DEL PEAK 42(18Q21.2) WILD-TYPE 4 18 76 6 312

Figure S407.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'Time to Death'

P value = 0.0051 (logrank test), Q value = 0.014

Table S408.  Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 43(18Q23) MUTATED 94 19 0.1 - 116.2 (20.0)
DEL PEAK 43(18Q23) WILD-TYPE 432 50 0.1 - 191.8 (23.9)

Figure S408.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

'del_18q23' versus 'YEARS_TO_BIRTH'

P value = 0.000443 (Wilcoxon-test), Q value = 0.0017

Table S409.  Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 43(18Q23) MUTATED 94 67.5 (10.2)
DEL PEAK 43(18Q23) WILD-TYPE 432 63.2 (11.3)

Figure S409.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S410.  Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 43(18Q23) MUTATED 37 6 52
DEL PEAK 43(18Q23) WILD-TYPE 358 15 60

Figure S410.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_18q23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.000482 (Fisher's exact test), Q value = 0.0018

Table S411.  Gene #94: 'del_18q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 43(18Q23) MUTATED 12 83
DEL PEAK 43(18Q23) WILD-TYPE 129 304

Figure S411.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_18q23' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0122 (Fisher's exact test), Q value = 0.029

Table S412.  Gene #94: 'del_18q23' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 43(18Q23) MUTATED 56 5 8 7
DEL PEAK 43(18Q23) WILD-TYPE 307 18 9 28

Figure S412.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_18q23' versus 'RACE'

P value = 0.0608 (Fisher's exact test), Q value = 0.11

Table S413.  Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 43(18Q23) MUTATED 1 2 26 3 57
DEL PEAK 43(18Q23) WILD-TYPE 3 18 75 6 309

Figure S413.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'ETHNICITY'

P value = 0.149 (Fisher's exact test), Q value = 0.24

Table S414.  Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 14 367
DEL PEAK 43(18Q23) MUTATED 5 65
DEL PEAK 43(18Q23) WILD-TYPE 9 302

Figure S414.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

'del_19p13.3' versus 'Time to Death'

P value = 7.09e-06 (logrank test), Q value = 5.9e-05

Table S415.  Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 44(19P13.3) MUTATED 150 35 0.1 - 125.4 (21.9)
DEL PEAK 44(19P13.3) WILD-TYPE 376 34 0.1 - 191.8 (23.8)

Figure S415.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

'del_19p13.3' versus 'YEARS_TO_BIRTH'

P value = 1.35e-10 (Wilcoxon-test), Q value = 4.7e-08

Table S416.  Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 44(19P13.3) MUTATED 150 68.6 (8.6)
DEL PEAK 44(19P13.3) WILD-TYPE 376 62.2 (11.6)

Figure S416.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S417.  Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 44(19P13.3) MUTATED 45 8 98
DEL PEAK 44(19P13.3) WILD-TYPE 350 13 14

Figure S417.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0815 (Fisher's exact test), Q value = 0.15

Table S418.  Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 44(19P13.3) MUTATED 32 119
DEL PEAK 44(19P13.3) WILD-TYPE 109 268

Figure S418.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_19p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00614 (Fisher's exact test), Q value = 0.016

Table S419.  Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 44(19P13.3) MUTATED 90 9 9 15
DEL PEAK 44(19P13.3) WILD-TYPE 273 14 8 20

Figure S419.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_19p13.3' versus 'RACE'

P value = 0.00027 (Fisher's exact test), Q value = 0.0011

Table S420.  Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 44(19P13.3) MUTATED 1 2 46 3 90
DEL PEAK 44(19P13.3) WILD-TYPE 3 18 55 6 276

Figure S420.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

'del_19p12' versus 'Time to Death'

P value = 0.0869 (logrank test), Q value = 0.16

Table S421.  Gene #96: 'del_19p12' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 45(19P12) MUTATED 57 12 0.2 - 116.2 (24.0)
DEL PEAK 45(19P12) WILD-TYPE 469 57 0.1 - 191.8 (23.3)

Figure S421.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #1: 'Time to Death'

'del_19p12' versus 'YEARS_TO_BIRTH'

P value = 0.0143 (Wilcoxon-test), Q value = 0.033

Table S422.  Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 45(19P12) MUTATED 56 67.2 (9.7)
DEL PEAK 45(19P12) WILD-TYPE 470 63.6 (11.3)

Figure S422.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S423.  Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 45(19P12) MUTATED 20 5 32
DEL PEAK 45(19P12) WILD-TYPE 375 16 80

Figure S423.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19p12' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0256 (Fisher's exact test), Q value = 0.055

Table S424.  Gene #96: 'del_19p12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 45(19P12) MUTATED 8 49
DEL PEAK 45(19P12) WILD-TYPE 133 338

Figure S424.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_19p12' versus 'RACE'

P value = 0.126 (Fisher's exact test), Q value = 0.21

Table S425.  Gene #96: 'del_19p12' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 45(19P12) MUTATED 1 1 17 1 34
DEL PEAK 45(19P12) WILD-TYPE 3 19 84 8 332

Figure S425.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #6: 'RACE'

'del_19q13.43' versus 'Time to Death'

P value = 0.00191 (logrank test), Q value = 0.0061

Table S426.  Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 46(19Q13.43) MUTATED 64 16 0.1 - 125.4 (21.9)
DEL PEAK 46(19Q13.43) WILD-TYPE 462 53 0.1 - 191.8 (23.4)

Figure S426.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

'del_19q13.43' versus 'YEARS_TO_BIRTH'

P value = 0.000307 (Wilcoxon-test), Q value = 0.0012

Table S427.  Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 46(19Q13.43) MUTATED 64 68.3 (9.7)
DEL PEAK 46(19Q13.43) WILD-TYPE 462 63.4 (11.3)

Figure S427.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19q13.43' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S428.  Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 46(19Q13.43) MUTATED 19 4 42
DEL PEAK 46(19Q13.43) WILD-TYPE 376 17 70

Figure S428.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19q13.43' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0255 (Fisher's exact test), Q value = 0.055

Table S429.  Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 46(19Q13.43) MUTATED 36 6 3 7
DEL PEAK 46(19Q13.43) WILD-TYPE 327 17 14 28

Figure S429.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_20p12.1' versus 'Time to Death'

P value = 8.85e-05 (logrank test), Q value = 0.00043

Table S430.  Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 47(20P12.1) MUTATED 35 13 0.3 - 149.6 (21.9)
DEL PEAK 47(20P12.1) WILD-TYPE 491 56 0.1 - 191.8 (23.4)

Figure S430.  Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

'del_20p12.1' versus 'YEARS_TO_BIRTH'

P value = 0.14 (Wilcoxon-test), Q value = 0.23

Table S431.  Gene #98: 'del_20p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 47(20P12.1) MUTATED 34 66.9 (10.4)
DEL PEAK 47(20P12.1) WILD-TYPE 492 63.8 (11.3)

Figure S431.  Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_20p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 2e-04 (Fisher's exact test), Q value = 0.00086

Table S432.  Gene #98: 'del_20p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 47(20P12.1) MUTATED 16 2 17
DEL PEAK 47(20P12.1) WILD-TYPE 379 19 95

Figure S432.  Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_20p12.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S433.  Gene #98: 'del_20p12.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 47(20P12.1) MUTATED 20 1 2 5
DEL PEAK 47(20P12.1) WILD-TYPE 343 22 15 30

Figure S433.  Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_22q13.32' versus 'Time to Death'

P value = 0.000218 (logrank test), Q value = 0.00092

Table S434.  Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 48(22Q13.32) MUTATED 135 28 0.1 - 116.2 (20.0)
DEL PEAK 48(22Q13.32) WILD-TYPE 391 41 0.1 - 191.8 (24.3)

Figure S434.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

'del_22q13.32' versus 'YEARS_TO_BIRTH'

P value = 1.05e-07 (Wilcoxon-test), Q value = 4.6e-06

Table S435.  Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 48(22Q13.32) MUTATED 135 68.4 (9.5)
DEL PEAK 48(22Q13.32) WILD-TYPE 391 62.5 (11.4)

Figure S435.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_22q13.32' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S436.  Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 48(22Q13.32) MUTATED 54 10 72
DEL PEAK 48(22Q13.32) WILD-TYPE 341 11 40

Figure S436.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_22q13.32' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0242 (Fisher's exact test), Q value = 0.053

Table S437.  Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients NO YES
ALL 141 387
DEL PEAK 48(22Q13.32) MUTATED 26 110
DEL PEAK 48(22Q13.32) WILD-TYPE 115 277

Figure S437.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_22q13.32' versus 'RACE'

P value = 0.0157 (Fisher's exact test), Q value = 0.036

Table S438.  Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 48(22Q13.32) MUTATED 1 1 37 2 89
DEL PEAK 48(22Q13.32) WILD-TYPE 3 19 64 7 277

Figure S438.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

'del_xp21.1' versus 'Time to Death'

P value = 1.97e-05 (logrank test), Q value = 0.00011

Table S439.  Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 526 69 0.1 - 191.8 (23.3)
DEL PEAK 49(XP21.1) MUTATED 83 23 0.3 - 113.4 (20.1)
DEL PEAK 49(XP21.1) WILD-TYPE 443 46 0.1 - 191.8 (23.5)

Figure S439.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

'del_xp21.1' versus 'YEARS_TO_BIRTH'

P value = 0.000139 (Wilcoxon-test), Q value = 0.00064

Table S440.  Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 526 64.0 (11.2)
DEL PEAK 49(XP21.1) MUTATED 83 68.1 (9.3)
DEL PEAK 49(XP21.1) WILD-TYPE 443 63.2 (11.4)

Figure S440.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_xp21.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S441.  Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 395 21 112
DEL PEAK 49(XP21.1) MUTATED 31 3 50
DEL PEAK 49(XP21.1) WILD-TYPE 364 18 62

Figure S441.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_xp21.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.125 (Fisher's exact test), Q value = 0.21

Table S442.  Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients R0 R1 R2 RX
ALL 363 23 17 35
DEL PEAK 49(XP21.1) MUTATED 53 2 6 6
DEL PEAK 49(XP21.1) WILD-TYPE 310 21 11 29

Figure S442.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_xp21.1' versus 'RACE'

P value = 0.00411 (Fisher's exact test), Q value = 0.012

Table S443.  Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 20 101 9 366
DEL PEAK 49(XP21.1) MUTATED 1 1 28 1 47
DEL PEAK 49(XP21.1) WILD-TYPE 3 19 73 8 319

Figure S443.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

Methods & Data
Input
  • Copy number data file = all_lesions.txt from GISTIC pipeline

  • Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/UCEC-TP/15106279/transformed.cor.cli.txt

  • Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/UCEC-TP/15094079/UCEC-TP.merged_data.txt

  • Number of patients = 528

  • Number of significantly focal cnvs = 100

  • Number of selected clinical features = 7

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)